Compound_ID,SMILES,Source_DB,Organism,Assay_Type,Activity_Type,Value_nM,Units,Reference,Notes,InChIKey
20035379.0,CCCCCCCCCCCCc1ccc(O)c(O)c1O,PubChem,Helicobacter pylori,urease inhibition,IC50,168000,nM,20801557.0,"The synthesis, structure and activity evaluation of pyrogallol and catechol derivatives as Helicobacter pylori urease inhibitors.",AALDDVUYNHJZLY-UHFFFAOYSA-N
49844400.0,Oc1ccc(CCc2ccc(Br)cc2)c(O)c1O,PubChem,Helicobacter pylori,urease inhibition,IC50,48000,nM,20801557.0,"The synthesis, structure and activity evaluation of pyrogallol and catechol derivatives as Helicobacter pylori urease inhibitors.",CEIVIFOSSBXXNW-UHFFFAOYSA-N
49844561.0,COc1ccc(CCc2ccc(O)c(O)c2)cc1OC,PubChem,Helicobacter pylori,urease inhibition,IC50,22700,nM,20801557.0,"The synthesis, structure and activity evaluation of pyrogallol and catechol derivatives as Helicobacter pylori urease inhibitors.",CXWVVZKYYXBRDD-UHFFFAOYSA-N
49844556.0,CCCCCCCCCCc1ccc(O)c(O)c1O,PubChem,Helicobacter pylori,urease inhibition,IC50,124000,nM,20801557.0,"The synthesis, structure and activity evaluation of pyrogallol and catechol derivatives as Helicobacter pylori urease inhibitors.",DHNUDVPJBHJGEH-UHFFFAOYSA-N
49844403.0,COc1ccc(CCc2ccc(O)c(O)c2O)cc1OC,PubChem,Helicobacter pylori,urease inhibition,IC50,71000,nM,20801557.0,"The synthesis, structure and activity evaluation of pyrogallol and catechol derivatives as Helicobacter pylori urease inhibitors.",DULQZJTVWCALEB-UHFFFAOYSA-N
49844557.0,Oc1ccc(CCc2ccc(F)cc2)cc1O,PubChem,Helicobacter pylori,urease inhibition,IC50,19300,nM,20801557.0,"The synthesis, structure and activity evaluation of pyrogallol and catechol derivatives as Helicobacter pylori urease inhibitors.",DXJSPFXEFULYPV-UHFFFAOYSA-N
49844562.0,COc1ccc(CCc2cccc(Cl)c2)cc1OC,PubChem,Helicobacter pylori,urease inhibition,IC50,235000,nM,20801557.0,"The synthesis, structure and activity evaluation of pyrogallol and catechol derivatives as Helicobacter pylori urease inhibitors.",FOZAJUYUVHXGLZ-UHFFFAOYSA-N
16745298.0,Oc1ccc(CCc2ccc(O)c(O)c2O)cc1,PubChem,Helicobacter pylori,urease inhibition,IC50,32000,nM,20801557.0,"The synthesis, structure and activity evaluation of pyrogallol and catechol derivatives as Helicobacter pylori urease inhibitors.",GKANHXJCHWHGHJ-UHFFFAOYSA-N
238945.0,CCCCc1ccc(O)c(O)c1O,PubChem,Helicobacter pylori,urease inhibition,IC50,79000,nM,20801557.0,"The synthesis, structure and activity evaluation of pyrogallol and catechol derivatives as Helicobacter pylori urease inhibitors.",GQXLTCORASWCDH-UHFFFAOYSA-N
70761.0,CCc1ccc(O)c(O)c1,PubChem,Helicobacter pylori,urease inhibition,IC50,11100,nM,20801557.0,"The synthesis, structure and activity evaluation of pyrogallol and catechol derivatives as Helicobacter pylori urease inhibitors.",HFLGBNBLMBSXEM-UHFFFAOYSA-N
49844555.0,CCOc1ccc(CCc2ccc(O)c(O)c2O)cc1OCC,PubChem,Helicobacter pylori,urease inhibition,IC50,69000,nM,20801557.0,"The synthesis, structure and activity evaluation of pyrogallol and catechol derivatives as Helicobacter pylori urease inhibitors.",HGBQETNPAMDMEL-UHFFFAOYSA-N
50908655.0,Oc1ccc(CCc2ccc(O)c(O)c2)cc1,PubChem,Helicobacter pylori,urease inhibition,IC50,2850,nM,20801557.0,"The synthesis, structure and activity evaluation of pyrogallol and catechol derivatives as Helicobacter pylori urease inhibitors.",HPRNXGQVPZPZNM-UHFFFAOYSA-N
82061.0,CCCCCCCCc1ccc(O)c(O)c1,PubChem,Helicobacter pylori,urease inhibition,IC50,58000,nM,20801557.0,"The synthesis, structure and activity evaluation of pyrogallol and catechol derivatives as Helicobacter pylori urease inhibitors.",JHMFYGCCBMZPFM-UHFFFAOYSA-N
49844402.0,Oc1ccc(CCc2cccc(Br)c2)c(O)c1O,PubChem,Helicobacter pylori,urease inhibition,IC50,52000,nM,20801557.0,"The synthesis, structure and activity evaluation of pyrogallol and catechol derivatives as Helicobacter pylori urease inhibitors.",JPMAIQTYHBSOOU-UHFFFAOYSA-N
22662485.0,CCCCCCCCc1ccc(O)c(O)c1O,PubChem,Helicobacter pylori,urease inhibition,IC50,103000,nM,20801557.0,"The synthesis, structure and activity evaluation of pyrogallol and catechol derivatives as Helicobacter pylori urease inhibitors.",KHDJXKNWFZQZHT-UHFFFAOYSA-N
14368879.0,CCCCc1ccc(O)c(O)c1,PubChem,Helicobacter pylori,urease inhibition,IC50,23000,nM,20801557.0,"The synthesis, structure and activity evaluation of pyrogallol and catechol derivatives as Helicobacter pylori urease inhibitors.",LAVPWYRENKSWJM-UHFFFAOYSA-N
12958458.0,CCc1ccc(O)c(O)c1O,PubChem,Helicobacter pylori,urease inhibition,IC50,34000,nM,20801557.0,"The synthesis, structure and activity evaluation of pyrogallol and catechol derivatives as Helicobacter pylori urease inhibitors.",LJLXJBBGIPYQDM-UHFFFAOYSA-N
15086385.0,CCCCCCc1ccc(O)c(O)c1,PubChem,Helicobacter pylori,urease inhibition,IC50,45050,nM,20801557.0,"The synthesis, structure and activity evaluation of pyrogallol and catechol derivatives as Helicobacter pylori urease inhibitors.",LKYDZVCFMVHUST-UHFFFAOYSA-N
52943499.0,CCCCCCCCCCCCCCc1ccc(O)c(O)c1O,PubChem,Helicobacter pylori,urease inhibition,IC50,250000,nM,20801557.0,"The synthesis, structure and activity evaluation of pyrogallol and catechol derivatives as Helicobacter pylori urease inhibitors.",MDCTXWNNDLXVLU-UHFFFAOYSA-N
52942302.0,COc1ccc(CCc2ccc(O)cc2)cc1OC,PubChem,Helicobacter pylori,urease inhibition,IC50,204000,nM,20801557.0,"The synthesis, structure and activity evaluation of pyrogallol and catechol derivatives as Helicobacter pylori urease inhibitors.",MMNUJXJNLKOJSJ-UHFFFAOYSA-N
49844401.0,Oc1ccc(CCc2cccc(Cl)c2)c(O)c1O,PubChem,Helicobacter pylori,urease inhibition,IC50,50000,nM,20801557.0,"The synthesis, structure and activity evaluation of pyrogallol and catechol derivatives as Helicobacter pylori urease inhibitors.",QTRMZJJWBQMNCS-UHFFFAOYSA-N
19423878.0,COc1ccc(CCc2ccccc2O)cc1OC,PubChem,Helicobacter pylori,urease inhibition,IC50,227000,nM,20801557.0,"The synthesis, structure and activity evaluation of pyrogallol and catechol derivatives as Helicobacter pylori urease inhibitors.",RIRTUCMKBRKEEJ-UHFFFAOYSA-N
49844558.0,Oc1ccc(CCc2ccc(Cl)cc2)cc1O,PubChem,Helicobacter pylori,urease inhibition,IC50,29200,nM,20801557.0,"The synthesis, structure and activity evaluation of pyrogallol and catechol derivatives as Helicobacter pylori urease inhibitors.",SJYIDEAYMRNXEP-UHFFFAOYSA-N
49844701.0,COc1ccc(CCc2ccc(Cl)cc2)cc1OC,PubChem,Helicobacter pylori,urease inhibition,IC50,254000,nM,20801557.0,"The synthesis, structure and activity evaluation of pyrogallol and catechol derivatives as Helicobacter pylori urease inhibitors.",SSLFIAUELOPLEL-UHFFFAOYSA-N
49844559.0,Oc1ccc(CCc2cccc(Cl)c2)cc1O,PubChem,Helicobacter pylori,urease inhibition,IC50,55200,nM,20801557.0,"The synthesis, structure and activity evaluation of pyrogallol and catechol derivatives as Helicobacter pylori urease inhibitors.",UXRIXFDGGMTBAQ-UHFFFAOYSA-N
46195675.0,Oc1ccc(CCc2ccc(F)cc2)c(O)c1O,PubChem,Helicobacter pylori,urease inhibition,IC50,43000,nM,20801557.0,"The synthesis, structure and activity evaluation of pyrogallol and catechol derivatives as Helicobacter pylori urease inhibitors.",VBGJSVZUKFPNNE-UHFFFAOYSA-N
20035378.0,CCCCCCc1ccc(O)c(O)c1O,PubChem,Helicobacter pylori,urease inhibition,IC50,91000,nM,20801557.0,"The synthesis, structure and activity evaluation of pyrogallol and catechol derivatives as Helicobacter pylori urease inhibitors.",WCLULZBTCHTXCC-UHFFFAOYSA-N
49844560.0,Oc1ccc(CCc2cccc(Br)c2)cc1O,PubChem,Helicobacter pylori,urease inhibition,IC50,52900,nM,20801557.0,"The synthesis, structure and activity evaluation of pyrogallol and catechol derivatives as Helicobacter pylori urease inhibitors.",XLYONLUBLSILAZ-UHFFFAOYSA-N
49844399.0,Oc1ccc(CCc2ccc(Cl)cc2)c(O)c1O,PubChem,Helicobacter pylori,urease inhibition,IC50,47000,nM,20801557.0,"The synthesis, structure and activity evaluation of pyrogallol and catechol derivatives as Helicobacter pylori urease inhibitors.",ZOLLZRKQVNFBNN-UHFFFAOYSA-N
382975.0,Oc1ccc(C2COc3cc(O)ccc3C2)cc1,PubChem,Helicobacter pylori,urease inhibition,IC50,92900,nM,23567958.0,"Synthesis, structure-activity relationship analysis and kinetics study of reductive derivatives of flavonoids as Helicobacter pylori urease inhibitors.",ADFCQWZHKCXPAJ-UHFFFAOYSA-N
13940833.0,COc1ccc(C2=COc3cc(O)ccc3C2)cc1,PubChem,Helicobacter pylori,urease inhibition,IC50,86200,nM,23567958.0,"Synthesis, structure-activity relationship analysis and kinetics study of reductive derivatives of flavonoids as Helicobacter pylori urease inhibitors.",BWAUURSNSPNMMP-UHFFFAOYSA-N
3584988.0,COc1ccc(C(C)C(=O)c2ccc(O)cc2O)cc1,PubChem,Helicobacter pylori,urease inhibition,IC50,1050000,nM,23567958.0,"Synthesis, structure-activity relationship analysis and kinetics study of reductive derivatives of flavonoids as Helicobacter pylori urease inhibitors.",CCOJFDRSZSSKOG-UHFFFAOYSA-N
471.0,O=C1c2c(O)cc(O)cc2OC(c2ccc(O)c(O)c2)C1O,PubChem,Helicobacter pylori,urease inhibition,IC50,43700,nM,23567958.0,"Synthesis, structure-activity relationship analysis and kinetics study of reductive derivatives of flavonoids as Helicobacter pylori urease inhibitors.",CXQWRCVTCMQVQX-UHFFFAOYSA-N
72197321.0,Oc1ccc(C2=COc3c(ccc(O)c3O)C2)cc1,PubChem,Helicobacter pylori,urease inhibition,IC50/Ki,"745,5",nM,23567958.0,"Synthesis, structure-activity relationship analysis and kinetics study of reductive derivatives of flavonoids as Helicobacter pylori urease inhibitors.",FNWFQALKJWWHGK-UHFFFAOYSA-N
23652247.0,COc1ccc(C2COc3cc(O)ccc3C2)cc1,PubChem,Helicobacter pylori,urease inhibition,IC50,358000,nM,23567958.0,"Synthesis, structure-activity relationship analysis and kinetics study of reductive derivatives of flavonoids as Helicobacter pylori urease inhibitors.",FPRFNXQLWQOWED-UHFFFAOYSA-N
932.0,O=C1CC(c2ccc(O)cc2)Oc2cc(O)cc(O)c21,PubChem,Helicobacter pylori,urease inhibition,IC50,328000,nM,23567958.0,"Synthesis, structure-activity relationship analysis and kinetics study of reductive derivatives of flavonoids as Helicobacter pylori urease inhibitors.",FTVWIRXFELQLPI-UHFFFAOYSA-N
5281605.0,O=c1cc(-c2ccccc2)oc2cc(O)c(O)c(O)c12,PubChem,Helicobacter pylori,urease inhibition,IC50,291000,nM,23567958.0,"Synthesis, structure-activity relationship analysis and kinetics study of reductive derivatives of flavonoids as Helicobacter pylori urease inhibitors.",FXNFHKRTJBSTCS-UHFFFAOYSA-N
4551278.0,COc1ccc(C2COc3cc(OC)ccc3C2)cc1,PubChem,Helicobacter pylori,urease inhibition,IC50,1783000,nM,23567958.0,"Synthesis, structure-activity relationship analysis and kinetics study of reductive derivatives of flavonoids as Helicobacter pylori urease inhibitors.",GQMFGWWADOSNMX-UHFFFAOYSA-N
5280378.0,COc1ccc(-c2coc3cc(O)ccc3c2=O)cc1,PubChem,Helicobacter pylori,urease inhibition,IC50,2003000,nM,23567958.0,"Synthesis, structure-activity relationship analysis and kinetics study of reductive derivatives of flavonoids as Helicobacter pylori urease inhibitors.",HKQYGTCOTHHOMP-UHFFFAOYSA-N
5280445.0,O=c1cc(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12,PubChem,Helicobacter pylori,urease inhibition,IC50,35400,nM,23567958.0,"Synthesis, structure-activity relationship analysis and kinetics study of reductive derivatives of flavonoids as Helicobacter pylori urease inhibitors.",IQPNAANSBPBGFQ-UHFFFAOYSA-N
270058.0,COc1cc(O)c(C(=O)CCc2ccccc2)c(OC)c1,PubChem,Helicobacter pylori,urease inhibition,IC50,1668000,nM,23567958.0,"Synthesis, structure-activity relationship analysis and kinetics study of reductive derivatives of flavonoids as Helicobacter pylori urease inhibitors.",JAJFQMZJIQDRSX-UHFFFAOYSA-N
72197322.0,Oc1cc2c(c(O)c1O)C=CC(c1ccccc1)O2,PubChem,Helicobacter pylori,urease inhibition,IC50,22100,nM,23567958.0,"Synthesis, structure-activity relationship analysis and kinetics study of reductive derivatives of flavonoids as Helicobacter pylori urease inhibitors.",JKMBCZRFBXVQLU-UHFFFAOYSA-N
88881.0,COc1cc(OC)c2c(=O)cc(-c3ccccc3)oc2c1,PubChem,Helicobacter pylori,urease inhibition,IC50,2185000,nM,23567958.0,"Synthesis, structure-activity relationship analysis and kinetics study of reductive derivatives of flavonoids as Helicobacter pylori urease inhibitors.",JRFZSUMZAUHNSL-UHFFFAOYSA-N
72197320.0,COc1ccc(C2C=Cc3c(OC)c(OC)c(OC)c(OC)c3O2)cc1,PubChem,Helicobacter pylori,urease inhibition,IC50,4172000,nM,23567958.0,"Synthesis, structure-activity relationship analysis and kinetics study of reductive derivatives of flavonoids as Helicobacter pylori urease inhibitors.",KDIOCIVEYUHICX-UHFFFAOYSA-N
5280443.0,O=c1cc(-c2ccc(O)cc2)oc2cc(O)cc(O)c12,PubChem,Helicobacter pylori,urease inhibition,IC50,138000,nM,23567958.0,"Synthesis, structure-activity relationship analysis and kinetics study of reductive derivatives of flavonoids as Helicobacter pylori urease inhibitors.",KZNIFHPLKGYRTM-UHFFFAOYSA-N
136419.0,COc1ccc(-c2coc3cc(OC)ccc3c2=O)cc1,PubChem,Helicobacter pylori,urease inhibition,IC50,3527000,nM,23567958.0,"Synthesis, structure-activity relationship analysis and kinetics study of reductive derivatives of flavonoids as Helicobacter pylori urease inhibitors.",LPNBCGIVZXHHHO-UHFFFAOYSA-N
25192450.0,Oc1cc(O)c2c(c1)OC(c1ccc(O)c(O)c1)C=C2,PubChem,Helicobacter pylori,urease inhibition,IC50,4420,nM,23567958.0,"Synthesis, structure-activity relationship analysis and kinetics study of reductive derivatives of flavonoids as Helicobacter pylori urease inhibitors.",MCOMSYCLUGORMY-UHFFFAOYSA-N
169676.0,COc1cc(O)c(C(=O)CCc2ccccc2)c(O)c1,PubChem,Helicobacter pylori,urease inhibition,IC50,978000,nM,23567958.0,"Synthesis, structure-activity relationship analysis and kinetics study of reductive derivatives of flavonoids as Helicobacter pylori urease inhibitors.",MDMCODCJMHTFIZ-UHFFFAOYSA-N
14284966.0,COc1ccc(C(C)C(=O)c2ccc(OC)cc2O)cc1,PubChem,Helicobacter pylori,urease inhibition,IC50,2178000,nM,23567958.0,"Synthesis, structure-activity relationship analysis and kinetics study of reductive derivatives of flavonoids as Helicobacter pylori urease inhibitors.",MSNJGHGEOPDPGD-UHFFFAOYSA-N
10955673.0,Oc1cc(O)c2c(c1)OC(c1ccccc1)C=C2,PubChem,Helicobacter pylori,urease inhibition,IC50,33200,nM,23567958.0,"Synthesis, structure-activity relationship analysis and kinetics study of reductive derivatives of flavonoids as Helicobacter pylori urease inhibitors.",OLKAZOSRXWPGPU-UHFFFAOYSA-N
5356121.0,COc1cc(O)c(C(=O)/C=C/c2ccccc2)c(OC)c1,PubChem,Helicobacter pylori,urease inhibition,IC50,1220000,nM,23567958.0,"Synthesis, structure-activity relationship analysis and kinetics study of reductive derivatives of flavonoids as Helicobacter pylori urease inhibitors.",QKQLSQLKXBHUSO-CMDGGOBGSA-N
5281607.0,O=c1cc(-c2ccccc2)oc2cc(O)cc(O)c12,PubChem,Helicobacter pylori,urease inhibition,IC50,302000,nM,23567958.0,"Synthesis, structure-activity relationship analysis and kinetics study of reductive derivatives of flavonoids as Helicobacter pylori urease inhibitors.",RTIXKCRFFJGDFG-UHFFFAOYSA-N
68077.0,COc1ccc(-c2cc(=O)c3c(OC)c(OC)c(OC)c(OC)c3o2)cc1,PubChem,Helicobacter pylori,urease inhibition,IC50,4628000,nM,23567958.0,"Synthesis, structure-activity relationship analysis and kinetics study of reductive derivatives of flavonoids as Helicobacter pylori urease inhibitors.",ULSUXBXHSYSGDT-UHFFFAOYSA-N
15533938.0,COc1ccc(C2COc3cc(OC)ccc3C2O)cc1,PubChem,Helicobacter pylori,urease inhibition,IC50,3867000,nM,23567958.0,"Synthesis, structure-activity relationship analysis and kinetics study of reductive derivatives of flavonoids as Helicobacter pylori urease inhibitors.",VYLSFZILUOILHT-UHFFFAOYSA-N
66548537.0,COc1ccc(C2CC(O)c3c(OC)c(OC)c(OC)c(OC)c3O2)cc1,PubChem,Helicobacter pylori,urease inhibition,IC50,4853000,nM,23567958.0,"Synthesis, structure-activity relationship analysis and kinetics study of reductive derivatives of flavonoids as Helicobacter pylori urease inhibitors.",VZTGDNRRQPPAIT-UHFFFAOYSA-N
60164496.0,COc1ccc(C2=CCc3c(OC)c(OC)c(OC)c(OC)c3O2)cc1,PubChem,Helicobacter pylori,urease inhibition,IC50,3791000,nM,23567958.0,"Synthesis, structure-activity relationship analysis and kinetics study of reductive derivatives of flavonoids as Helicobacter pylori urease inhibitors.",ZHOGDWOJCUYFSR-UHFFFAOYSA-N
5281708.0,O=c1c(-c2ccc(O)cc2)coc2cc(O)ccc12,PubChem,Helicobacter pylori,urease inhibition,IC50,556000,nM,23567958.0,"Synthesis, structure-activity relationship analysis and kinetics study of reductive derivatives of flavonoids as Helicobacter pylori urease inhibitors.",ZQSIJRDFPHDXIC-UHFFFAOYSA-N
72707600.0,O=C(CC(O)c1ccccc1F)NO,PubChem,Helicobacter pylori,urease inhibition,IC50,5600,nM,23974021.0,"Synthesis, molecular docking and kinetic properties of β-hydroxy-β-phenylpropionyl-hydroxamic acids as Helicobacter pylori urease inhibitors.",ADFZLHXYATZWSH-UHFFFAOYSA-N
72707672.0,O=C(CC(O)c1ccc(Cl)c(Cl)c1)NO,PubChem,Helicobacter pylori,urease inhibition,IC50,895,nM,23974021.0,"Synthesis, molecular docking and kinetic properties of β-hydroxy-β-phenylpropionyl-hydroxamic acids as Helicobacter pylori urease inhibitors.",FLLNJABKBTYQGF-UHFFFAOYSA-N
72707671.0,O=C(CC(O)c1cccc(Cl)c1Cl)NO,PubChem,Helicobacter pylori,urease inhibition,IC50/Ki,230,nM,23974021.0,"Synthesis, molecular docking and kinetic properties of β-hydroxy-β-phenylpropionyl-hydroxamic acids as Helicobacter pylori urease inhibitors.",FOXDYWSFBSJBQQ-UHFFFAOYSA-N
72707668.0,O=C(CC(O)c1ccc(F)cc1)NO,PubChem,Helicobacter pylori,urease inhibition,IC50,8010,nM,23974021.0,"Synthesis, molecular docking and kinetic properties of β-hydroxy-β-phenylpropionyl-hydroxamic acids as Helicobacter pylori urease inhibitors.",FSKOQKSDUBTQCK-UHFFFAOYSA-N
72707673.0,COc1ccc(F)cc1C(O)CC(=O)NO,PubChem,Helicobacter pylori,urease inhibition,IC50,11000,nM,23974021.0,"Synthesis, molecular docking and kinetic properties of β-hydroxy-β-phenylpropionyl-hydroxamic acids as Helicobacter pylori urease inhibitors.",HJZGIXVWMCCKMU-UHFFFAOYSA-N
72707598.0,COc1ccccc1C(O)CC(=O)NO,PubChem,Helicobacter pylori,urease inhibition,IC50,38500,nM,23974021.0,"Synthesis, molecular docking and kinetic properties of β-hydroxy-β-phenylpropionyl-hydroxamic acids as Helicobacter pylori urease inhibitors.",HKRSBCYRZIIQME-UHFFFAOYSA-N
72707669.0,O=C(CC(O)c1ccc(C(F)(F)F)cc1)NO,PubChem,Helicobacter pylori,urease inhibition,IC50,7890,nM,23974021.0,"Synthesis, molecular docking and kinetic properties of β-hydroxy-β-phenylpropionyl-hydroxamic acids as Helicobacter pylori urease inhibitors.",IBFNZPDYLZCKOS-UHFFFAOYSA-N
72707742.0,O=C(CC(O)c1cc(Cl)cc(Cl)c1O)NO,PubChem,Helicobacter pylori,urease inhibition,IC50,4970,nM,23974021.0,"Synthesis, molecular docking and kinetic properties of β-hydroxy-β-phenylpropionyl-hydroxamic acids as Helicobacter pylori urease inhibitors.",JUEDDYGDNNQQSN-UHFFFAOYSA-N
71721720.0,O=C(CC(O)c1ccccc1)NO,PubChem,Helicobacter pylori,urease inhibition,IC50,15600,nM,23974021.0,"Synthesis, molecular docking and kinetic properties of β-hydroxy-β-phenylpropionyl-hydroxamic acids as Helicobacter pylori urease inhibitors.",KMRDEISJTGZABX-UHFFFAOYSA-N
72707664.0,O=C(CC(O)c1cccc(C(F)(F)F)c1)NO,PubChem,Helicobacter pylori,urease inhibition,IC50,4015,nM,23974021.0,"Synthesis, molecular docking and kinetic properties of β-hydroxy-β-phenylpropionyl-hydroxamic acids as Helicobacter pylori urease inhibitors.",KZJHIWWUCORXIF-UHFFFAOYSA-N
72707667.0,O=C(CC(O)c1ccc(Cl)cc1)NO,PubChem,Helicobacter pylori,urease inhibition,IC50,3390,nM,23974021.0,"Synthesis, molecular docking and kinetic properties of β-hydroxy-β-phenylpropionyl-hydroxamic acids as Helicobacter pylori urease inhibitors.",LNIGBUSWLZDUPU-UHFFFAOYSA-N
72707602.0,COc1cccc(C(O)CC(=O)NO)c1,PubChem,Helicobacter pylori,urease inhibition,IC50,23200,nM,23974021.0,"Synthesis, molecular docking and kinetic properties of β-hydroxy-β-phenylpropionyl-hydroxamic acids as Helicobacter pylori urease inhibitors.",LRMXIYJORHWOCX-UHFFFAOYSA-N
72707665.0,COc1ccc(C(O)CC(=O)NO)cc1,PubChem,Helicobacter pylori,urease inhibition,IC50,75100,nM,23974021.0,"Synthesis, molecular docking and kinetic properties of β-hydroxy-β-phenylpropionyl-hydroxamic acids as Helicobacter pylori urease inhibitors.",OPODPBQULVPNHN-UHFFFAOYSA-N
72707603.0,O=C(CC(O)c1cccc(F)c1)NO,PubChem,Helicobacter pylori,urease inhibition,IC50,8645,nM,23974021.0,"Synthesis, molecular docking and kinetic properties of β-hydroxy-β-phenylpropionyl-hydroxamic acids as Helicobacter pylori urease inhibitors.",QHRFRWZEQGWNSO-UHFFFAOYSA-N
72707599.0,O=C(CC(O)c1ccccc1Cl)NO,PubChem,Helicobacter pylori,urease inhibition,IC50,5200,nM,23974021.0,"Synthesis, molecular docking and kinetic properties of β-hydroxy-β-phenylpropionyl-hydroxamic acids as Helicobacter pylori urease inhibitors.",QJSZYBJGKUZWKJ-UHFFFAOYSA-N
72707666.0,O=C(CC(O)c1ccc(OCc2ccccc2)cc1)NO,PubChem,Helicobacter pylori,urease inhibition,IC50,61500,nM,23974021.0,"Synthesis, molecular docking and kinetic properties of β-hydroxy-β-phenylpropionyl-hydroxamic acids as Helicobacter pylori urease inhibitors.",VDLJOYYXZLZHFP-UHFFFAOYSA-N
307149.0,CN(C)c1ccc(C(=O)NO)cc1,PubChem,Helicobacter pylori,urease inhibition,IC50,77900,nM,23974021.0,"Synthesis, molecular docking and kinetic properties of β-hydroxy-β-phenylpropionyl-hydroxamic acids as Helicobacter pylori urease inhibitors.",VFRVHRMFCRFTKS-UHFFFAOYSA-N
72707601.0,O=C(CC(O)c1cccc(O)c1)NO,PubChem,Helicobacter pylori,urease inhibition,IC50,131000,nM,23974021.0,"Synthesis, molecular docking and kinetic properties of β-hydroxy-β-phenylpropionyl-hydroxamic acids as Helicobacter pylori urease inhibitors.",YHZVXWISURHQRS-UHFFFAOYSA-N
72707670.0,CN(C)c1ccc(C(O)CC(=O)NO)cc1,PubChem,Helicobacter pylori,urease inhibition,IC50,7130,nM,23974021.0,"Synthesis, molecular docking and kinetic properties of β-hydroxy-β-phenylpropionyl-hydroxamic acids as Helicobacter pylori urease inhibitors.",YLDDZIXESVZIFQ-UHFFFAOYSA-N
71721723.0,O=C(CC(O)c1cc(Cl)ccc1O)NO,PubChem,Helicobacter pylori,urease inhibition,IC50,1280,nM,23974021.0/27492194.0,"3-Arylpropionylhydroxamic acid derivatives as Helicobacter pylori urease inhibitors: Synthesis, molecular docking and biological evaluation./Synthesis, molecular docking and kinetic properties of β-hydroxy-β-phenylpropionyl-hydroxamic acids as Helicobacter pylori urease inhibitors.",LZJAUAHHHSKTAK-UHFFFAOYSA-N
71721721.0,O=C(CC(O)c1cccc(Cl)c1)NO,PubChem,Helicobacter pylori,urease inhibition,IC50/Ki,83,nM,23974021.0/35305460.0,"An overview on the synthetic urease inhibitors with structure-activity relationship and molecular docking./Synthesis, molecular docking and kinetic properties of β-hydroxy-β-phenylpropionyl-hydroxamic acids as Helicobacter pylori urease inhibitors.",RGSGSSVNDBRBSG-UHFFFAOYSA-N
155535566.0,CN(O)C(=O)CC(O)c1ccc(Cl)cc1Cl,PubChem,Helicobacter pylori,urease inhibition,IC50,367000,nM,27492194.0,"3-Arylpropionylhydroxamic acid derivatives as Helicobacter pylori urease inhibitors: Synthesis, molecular docking and biological evaluation.",ALTQFFMPMROPOS-UHFFFAOYSA-N
155546770.0,CN(O)C(=O)CC(O)c1ccc(OCc2ccccc2)cc1,PubChem,Helicobacter pylori,urease inhibition,IC50,198000,nM,27492194.0,"3-Arylpropionylhydroxamic acid derivatives as Helicobacter pylori urease inhibitors: Synthesis, molecular docking and biological evaluation.",AQDMVXJLQSLNAB-UHFFFAOYSA-N
155565349.0,CN(O)C(=O)CC(O)c1c(Cl)cccc1Cl,PubChem,Helicobacter pylori,urease inhibition,IC50,77900,nM,27492194.0,"3-Arylpropionylhydroxamic acid derivatives as Helicobacter pylori urease inhibitors: Synthesis, molecular docking and biological evaluation.",BTQLSSLFYWVJBE-UHFFFAOYSA-N
155514177.0,CN(O)C(=O)CC(O)c1ccc(F)cc1,PubChem,Helicobacter pylori,urease inhibition,IC50,77200,nM,27492194.0,"3-Arylpropionylhydroxamic acid derivatives as Helicobacter pylori urease inhibitors: Synthesis, molecular docking and biological evaluation.",DEUYXPYQDCTVOM-UHFFFAOYSA-N
155560525.0,CN(O)C(=O)CC(O)c1cc(Cl)ccc1OCc1ccccc1,PubChem,Helicobacter pylori,urease inhibition,IC50,26200,nM,27492194.0,"3-Arylpropionylhydroxamic acid derivatives as Helicobacter pylori urease inhibitors: Synthesis, molecular docking and biological evaluation.",GRSPEAHRJCOVAI-UHFFFAOYSA-N
71727110.0,CN(O)C(=O)CC(O)c1cc(Cl)ccc1O,PubChem,Helicobacter pylori,urease inhibition,IC50,30500,nM,27492194.0,"3-Arylpropionylhydroxamic acid derivatives as Helicobacter pylori urease inhibitors: Synthesis, molecular docking and biological evaluation.",HPOHTFNGSSOVQC-UHFFFAOYSA-N
155553304.0,O=C(CC(O)c1ccc(Cl)cc1Cl)NO,PubChem,Helicobacter pylori,urease inhibition,IC50,13400,nM,27492194.0,"3-Arylpropionylhydroxamic acid derivatives as Helicobacter pylori urease inhibitors: Synthesis, molecular docking and biological evaluation.",ICXJMRZQQYLVJY-UHFFFAOYSA-N
155528209.0,CN(O)C(=O)CC(O)c1ccc(Br)cc1,PubChem,Helicobacter pylori,urease inhibition,IC50,97600,nM,27492194.0,"3-Arylpropionylhydroxamic acid derivatives as Helicobacter pylori urease inhibitors: Synthesis, molecular docking and biological evaluation.",ILJOQGOHPRYRLB-UHFFFAOYSA-N
155546187.0,CN(O)C(=O)CC(O)c1ccc(Cl)c(Cl)c1,PubChem,Helicobacter pylori,urease inhibition,IC50,90400,nM,27492194.0,"3-Arylpropionylhydroxamic acid derivatives as Helicobacter pylori urease inhibitors: Synthesis, molecular docking and biological evaluation.",IVEMKCFSUXSZIE-UHFFFAOYSA-N
155562391.0,CN(O)C(=O)CC(O)c1cccc(F)c1,PubChem,Helicobacter pylori,urease inhibition,IC50,71200,nM,27492194.0,"3-Arylpropionylhydroxamic acid derivatives as Helicobacter pylori urease inhibitors: Synthesis, molecular docking and biological evaluation.",LJLOTHHWPINGNI-UHFFFAOYSA-N
155540829.0,CN(O)C(=O)CC(O)c1cccc(Cl)c1,PubChem,Helicobacter pylori,urease inhibition,IC50,48000,nM,27492194.0,"3-Arylpropionylhydroxamic acid derivatives as Helicobacter pylori urease inhibitors: Synthesis, molecular docking and biological evaluation.",LQIRYLGIIOELHT-UHFFFAOYSA-N
71727108.0,CN(O)C(=O)CC(O)c1cccc(Cl)c1Cl,PubChem,Helicobacter pylori,urease inhibition,IC50,95800,nM,27492194.0,"3-Arylpropionylhydroxamic acid derivatives as Helicobacter pylori urease inhibitors: Synthesis, molecular docking and biological evaluation.",MRWPQKCIHWNUSH-UHFFFAOYSA-N
155557124.0,CN(O)C(=O)CC(O)c1ccccc1Cl,PubChem,Helicobacter pylori,urease inhibition,IC50,56600,nM,27492194.0,"3-Arylpropionylhydroxamic acid derivatives as Helicobacter pylori urease inhibitors: Synthesis, molecular docking and biological evaluation.",NOUZUBYISNDSJZ-UHFFFAOYSA-N
155538391.0,COc1cc(C(O)CC(=O)N(C)O)ccc1OCc1ccccc1,PubChem,Helicobacter pylori,urease inhibition,IC50,258000,nM,27492194.0,"3-Arylpropionylhydroxamic acid derivatives as Helicobacter pylori urease inhibitors: Synthesis, molecular docking and biological evaluation.",OLBMMGNYDILXAG-UHFFFAOYSA-N
155512668.0,CN(O)C(=O)CC(O)c1ccc(N(C)C)cc1,PubChem,Helicobacter pylori,urease inhibition,IC50,287000,nM,27492194.0,"3-Arylpropionylhydroxamic acid derivatives as Helicobacter pylori urease inhibitors: Synthesis, molecular docking and biological evaluation.",SSEWQCPQQUTVNQ-UHFFFAOYSA-N
155523859.0,COc1ccc(C(O)CC(=O)N(C)O)cc1,PubChem,Helicobacter pylori,urease inhibition,IC50,328000,nM,27492194.0,"3-Arylpropionylhydroxamic acid derivatives as Helicobacter pylori urease inhibitors: Synthesis, molecular docking and biological evaluation.",TZNKDWUSWZBIAP-UHFFFAOYSA-N
155546402.0,CN(O)C(=O)CC(O)c1ccc(OCc2ccccc2)c(OCc2ccccc2)c1,PubChem,Helicobacter pylori,urease inhibition,IC50,376000,nM,27492194.0,"3-Arylpropionylhydroxamic acid derivatives as Helicobacter pylori urease inhibitors: Synthesis, molecular docking and biological evaluation.",VPGGVFDKMHYFJL-UHFFFAOYSA-N
155536133.0,CN(O)C(=O)CC(O)c1ccc(Cl)cc1,PubChem,Helicobacter pylori,urease inhibition,IC50,87400,nM,27492194.0,"3-Arylpropionylhydroxamic acid derivatives as Helicobacter pylori urease inhibitors: Synthesis, molecular docking and biological evaluation.",WFNSGANXAQPYGP-UHFFFAOYSA-N
155519422.0,COc1ccc(C(O)CC(=O)N(C)O)cc1OC,PubChem,Helicobacter pylori,urease inhibition,IC50,405000,nM,27492194.0,"3-Arylpropionylhydroxamic acid derivatives as Helicobacter pylori urease inhibitors: Synthesis, molecular docking and biological evaluation.",WHZBPNPYUBGFOM-UHFFFAOYSA-N
155534689.0,CN(O)C(=O)CC(O)c1cccc(Br)c1,PubChem,Helicobacter pylori,urease inhibition,IC50,78200,nM,27492194.0,"3-Arylpropionylhydroxamic acid derivatives as Helicobacter pylori urease inhibitors: Synthesis, molecular docking and biological evaluation.",XOCYAQHDFFMPDV-UHFFFAOYSA-N
155550012.0,COc1ccccc1C(O)CC(=O)N(C)O,PubChem,Helicobacter pylori,urease inhibition,IC50,84000,nM,27492194.0,"3-Arylpropionylhydroxamic acid derivatives as Helicobacter pylori urease inhibitors: Synthesis, molecular docking and biological evaluation.",YGUJVGVSZBRFHL-UHFFFAOYSA-N
155547948.0,COc1cccc(C(O)CC(=O)N(C)O)c1,PubChem,Helicobacter pylori,urease inhibition,IC50,89200,nM,27492194.0,"3-Arylpropionylhydroxamic acid derivatives as Helicobacter pylori urease inhibitors: Synthesis, molecular docking and biological evaluation.",ZXSKZAGDPZNYIZ-UHFFFAOYSA-N
145993094.0,COc1cc(OC)cc(C(=O)N=Nc2c(O)n(CC=C(C)C)c3ccccc23)c1,PubChem,Helicobacter pylori,urease inhibition,IC50/MIC,1655,nM,30170940.0,"Developing potential Helicobacter pylori urease inhibitors from novel oxoindoline derivatives: Synthesis, biological evaluation and in silico study.",ARWVSXHSSMXFEI-UHFFFAOYSA-N
145980667.0,COc1cccc(C(=O)N=Nc2c(O)n(CC=C(C)C)c3ccccc23)c1,PubChem,Helicobacter pylori,urease inhibition,IC50/MIC,11705,nM,30170940.0,"Developing potential Helicobacter pylori urease inhibitors from novel oxoindoline derivatives: Synthesis, biological evaluation and in silico study.",BJJZTGYVMKGOEY-UHFFFAOYSA-N
145989286.0,CC(C)=CCn1c(O)c(N=NC(=O)c2ccc(C)cc2)c2ccccc21,PubChem,Helicobacter pylori,urease inhibition,IC50/MIC,44000,nM,30170940.0,"Developing potential Helicobacter pylori urease inhibitors from novel oxoindoline derivatives: Synthesis, biological evaluation and in silico study.",DZWPARINBHPZFS-UHFFFAOYSA-N
145990691.0,COc1ccc(C(=O)N=Nc2c(O)n(CC=C(C)C)c3ccccc23)cc1,PubChem,Helicobacter pylori,urease inhibition,IC50/MIC,8645,nM,30170940.0,"Developing potential Helicobacter pylori urease inhibitors from novel oxoindoline derivatives: Synthesis, biological evaluation and in silico study.",FAWQUERWOQMSNI-UHFFFAOYSA-N
145988430.0,COc1ccccc1C(=O)N=Nc1c(O)n(CC=C(C)C)c2ccccc12,PubChem,Helicobacter pylori,urease inhibition,IC50/MIC,15600,nM,30170940.0,"Developing potential Helicobacter pylori urease inhibitors from novel oxoindoline derivatives: Synthesis, biological evaluation and in silico study.",FXUOIBSGDDQSJP-UHFFFAOYSA-N
145986843.0,CC(C)=CCn1c(O)c(N=NC(=O)c2cccc(Br)c2)c2ccccc21,PubChem,Helicobacter pylori,urease inhibition,IC50/MIC,39050,nM,30170940.0,"Developing potential Helicobacter pylori urease inhibitors from novel oxoindoline derivatives: Synthesis, biological evaluation and in silico study.",GAFWMEOUNHOHCU-UHFFFAOYSA-N
145980829.0,CC(C)=CCn1c(O)c(N=NC(=O)c2ccc(Br)cc2)c2ccccc21,PubChem,Helicobacter pylori,urease inhibition,IC50/MIC,110450,nM,30170940.0,"Developing potential Helicobacter pylori urease inhibitors from novel oxoindoline derivatives: Synthesis, biological evaluation and in silico study.",HHUNQGGMAAPGBH-UHFFFAOYSA-N
145981870.0,CC(C)=CCn1c(O)c(N=NC(=O)c2cc(C)cc(C)c2)c2ccccc21,PubChem,Helicobacter pylori,urease inhibition,IC50/MIC,5565,nM,30170940.0,"Developing potential Helicobacter pylori urease inhibitors from novel oxoindoline derivatives: Synthesis, biological evaluation and in silico study.",KVKCOUJPRHORPD-UHFFFAOYSA-N
145993983.0,CC(C)=CCn1c(O)c(N=NC(=O)c2ccc(Oc3ccccc3)cc2)c2ccccc21,PubChem,Helicobacter pylori,urease inhibition,IC50/MIC,32250,nM,30170940.0,"Developing potential Helicobacter pylori urease inhibitors from novel oxoindoline derivatives: Synthesis, biological evaluation and in silico study.",LDTSXKSVUXHVSK-UHFFFAOYSA-N
145979868.0,CC(C)=CCn1c(O)c(N=NC(=O)c2ccc(C(C)C)cc2)c2ccccc21,PubChem,Helicobacter pylori,urease inhibition,IC50/MIC,21200,nM,30170940.0,"Developing potential Helicobacter pylori urease inhibitors from novel oxoindoline derivatives: Synthesis, biological evaluation and in silico study.",LPEMHSPVVVSEFY-UHFFFAOYSA-N
145980959.0,CC(C)=CCn1c(O)c(N=NC(=O)c2cccc(Cl)c2)c2ccccc21,PubChem,Helicobacter pylori,urease inhibition,IC50/MIC,55300,nM,30170940.0,"Developing potential Helicobacter pylori urease inhibitors from novel oxoindoline derivatives: Synthesis, biological evaluation and in silico study.",MSOBQFFBRUWDSH-UHFFFAOYSA-N
145980462.0,CC(C)=CCn1c(O)c(N=NC(=O)c2ccc(C(F)(F)F)cc2)c2ccccc21,PubChem,Helicobacter pylori,urease inhibition,IC50/MIC,64000,nM,30170940.0,"Developing potential Helicobacter pylori urease inhibitors from novel oxoindoline derivatives: Synthesis, biological evaluation and in silico study.",NVXHFOODAQXYBL-UHFFFAOYSA-N
145990246.0,CC(C)=CCn1c(O)c(N=NC(=O)c2ccc(F)cc2)c2ccccc21,PubChem,Helicobacter pylori,urease inhibition,IC50/MIC,177000,nM,30170940.0,"Developing potential Helicobacter pylori urease inhibitors from novel oxoindoline derivatives: Synthesis, biological evaluation and in silico study.",PTYZHZGJDHNHNO-UHFFFAOYSA-N
145986522.0,CC(C)=CCn1c(O)c(N=NC(=O)c2cccc(C(F)(F)F)c2)c2ccccc21,PubChem,Helicobacter pylori,urease inhibition,IC50/MIC,86900,nM,30170940.0,"Developing potential Helicobacter pylori urease inhibitors from novel oxoindoline derivatives: Synthesis, biological evaluation and in silico study.",UFFIYOCVTSSAHT-UHFFFAOYSA-N
145993469.0,COc1ccc(C(=O)N=Nc2c(O)n(CC=C(C)C)c3ccccc23)cc1OC,PubChem,Helicobacter pylori,urease inhibition,IC50/MIC,595,nM,30170940.0,"Developing potential Helicobacter pylori urease inhibitors from novel oxoindoline derivatives: Synthesis, biological evaluation and in silico study.",VFCCZOBUJKAKQF-UHFFFAOYSA-N
145987122.0,CC(C)=CCn1c(O)c(N=NC(=O)c2ccc(C(C)(C)C)cc2)c2ccccc21,PubChem,Helicobacter pylori,urease inhibition,IC50/MIC,25150,nM,30170940.0,"Developing potential Helicobacter pylori urease inhibitors from novel oxoindoline derivatives: Synthesis, biological evaluation and in silico study.",WBJVMCAIHZOLET-UHFFFAOYSA-N
145993563.0,CC(C)=CCn1c(O)c(N=NC(=O)c2ccc(Cl)cc2)c2ccccc21,PubChem,Helicobacter pylori,urease inhibition,IC50/MIC,164000,nM,30170940.0,"Developing potential Helicobacter pylori urease inhibitors from novel oxoindoline derivatives: Synthesis, biological evaluation and in silico study.",WNVKQCSQSMTJAB-UHFFFAOYSA-N
145988267.0,CC(C)=CCn1c(O)c(N=NC(=O)c2ccccc2)c2ccccc21,PubChem,Helicobacter pylori,urease inhibition,IC50/MIC,150000,nM,30170940.0,"Developing potential Helicobacter pylori urease inhibitors from novel oxoindoline derivatives: Synthesis, biological evaluation and in silico study.",XOPKGISFZWZSIB-UHFFFAOYSA-N
145985856.0,COc1ccc(C(=O)N=Nc2c(O)n(CC=C(C)C)c3ccccc23)cc1F,PubChem,Helicobacter pylori,urease inhibition,IC50/MIC,3880,nM,30170940.0,"Developing potential Helicobacter pylori urease inhibitors from novel oxoindoline derivatives: Synthesis, biological evaluation and in silico study.",YBCNPHIFENBQHH-UHFFFAOYSA-N
168282573.0,O=C(COc1ccc(CC2C(=O)NC(=O)NC2=O)cc1)Nc1cccc(Cl)c1Cl,PubChem,Helicobacter pylori,urease inhibition,IC50,690,nM,35305460.0,An overview on the synthetic urease inhibitors with structure-activity relationship and molecular docking.,YACFTEJPJSIJBS-UHFFFAOYSA-N
168288909.0,O=C(CN(c1cccc([N+](=O)[O-])c1)S(=O)(=O)c1ccccc1Cl)NO,PubChem,Helicobacter pylori,urease inhibition,IC50,22000,nM,36332883.0,"Synthesis, evaluation and mechanism exploration of 2-(N-(3-nitrophenyl)-N-phenylsulfonyl)aminoacetohydroxamic acids as novel urease inhibitors.",CEHMZNCGHJUNPZ-UHFFFAOYSA-N
168277096.0,O=C(CN(c1cccc([N+](=O)[O-])c1)S(=O)(=O)c1cc(Cl)ccc1Cl)NO,PubChem,Helicobacter pylori,urease inhibition,IC50,27500,nM,36332883.0,"Synthesis, evaluation and mechanism exploration of 2-(N-(3-nitrophenyl)-N-phenylsulfonyl)aminoacetohydroxamic acids as novel urease inhibitors.",JCFFBOGPJUBMHM-UHFFFAOYSA-N
168280507.0,O=C(CN(c1cccc([N+](=O)[O-])c1)S(=O)(=O)c1ccc(F)cc1)NO,PubChem,Helicobacter pylori,urease inhibition,IC50,3330,nM,36332883.0,"Synthesis, evaluation and mechanism exploration of 2-(N-(3-nitrophenyl)-N-phenylsulfonyl)aminoacetohydroxamic acids as novel urease inhibitors.",LLNIRUOKORBVLD-UHFFFAOYSA-N
168295046.0,O=C(CN(c1cccc([N+](=O)[O-])c1)S(=O)(=O)c1ccc(Br)cc1)NO,PubChem,Helicobacter pylori,urease inhibition,IC50/Kd/Ki,"97,5",nM,36332883.0,"Synthesis, evaluation and mechanism exploration of 2-(N-(3-nitrophenyl)-N-phenylsulfonyl)aminoacetohydroxamic acids as novel urease inhibitors.",MQGMNHQKJHOOPB-UHFFFAOYSA-N
168292848.0,O=C(CN(c1cccc([N+](=O)[O-])c1)S(=O)(=O)c1cc(F)ccc1F)NO,PubChem,Helicobacter pylori,urease inhibition,IC50,16400,nM,36332883.0,"Synthesis, evaluation and mechanism exploration of 2-(N-(3-nitrophenyl)-N-phenylsulfonyl)aminoacetohydroxamic acids as novel urease inhibitors.",MYRFLLXRWDHINM-UHFFFAOYSA-N
168279374.0,O=C(CN(c1cccc([N+](=O)[O-])c1)S(=O)(=O)c1ccc(Cl)cc1)NO,PubChem,Helicobacter pylori,urease inhibition,IC50,1750,nM,36332883.0,"Synthesis, evaluation and mechanism exploration of 2-(N-(3-nitrophenyl)-N-phenylsulfonyl)aminoacetohydroxamic acids as novel urease inhibitors.",NJKONZNHPAOMJC-UHFFFAOYSA-N
168294924.0,Cc1ccc(S(=O)(=O)N(CC(=O)NO)c2cccc([N+](=O)[O-])c2)cc1,PubChem,Helicobacter pylori,urease inhibition,IC50,5910,nM,36332883.0,"Synthesis, evaluation and mechanism exploration of 2-(N-(3-nitrophenyl)-N-phenylsulfonyl)aminoacetohydroxamic acids as novel urease inhibitors.",NZLRHPZUWPBJET-UHFFFAOYSA-N
168297531.0,O=C(CN(c1cccc([N+](=O)[O-])c1)S(=O)(=O)c1ccccc1)NO,PubChem,Helicobacter pylori,urease inhibition,IC50,2410,nM,36332883.0,"Synthesis, evaluation and mechanism exploration of 2-(N-(3-nitrophenyl)-N-phenylsulfonyl)aminoacetohydroxamic acids as novel urease inhibitors.",PPIQJNZVHVNZOD-UHFFFAOYSA-N
168277224.0,O=C(CN(c1cccc([N+](=O)[O-])c1)S(=O)(=O)c1ccccc1F)NO,PubChem,Helicobacter pylori,urease inhibition,IC50,6900,nM,36332883.0,"Synthesis, evaluation and mechanism exploration of 2-(N-(3-nitrophenyl)-N-phenylsulfonyl)aminoacetohydroxamic acids as novel urease inhibitors.",RDSYWVSUOKJKJT-UHFFFAOYSA-N
168296539.0,O=C(CN(c1cccc([N+](=O)[O-])c1)S(=O)(=O)c1cccc(F)c1)NO,PubChem,Helicobacter pylori,urease inhibition,IC50,740,nM,36332883.0,"Synthesis, evaluation and mechanism exploration of 2-(N-(3-nitrophenyl)-N-phenylsulfonyl)aminoacetohydroxamic acids as novel urease inhibitors.",VWABGOYOPIBDIT-UHFFFAOYSA-N
168289003.0,Cc1cc(C)c(S(=O)(=O)N(CC(=O)NO)c2cccc([N+](=O)[O-])c2)c(C)c1,PubChem,Helicobacter pylori,urease inhibition,IC50,96400,nM,36332883.0,"Synthesis, evaluation and mechanism exploration of 2-(N-(3-nitrophenyl)-N-phenylsulfonyl)aminoacetohydroxamic acids as novel urease inhibitors.",YHMXFDVOKIEIPD-UHFFFAOYSA-N
168295164.0,O=C(CN(c1cccc([N+](=O)[O-])c1)S(=O)(=O)c1ccc(C(F)(F)F)cc1)NO,PubChem,Helicobacter pylori,urease inhibition,IC50,9570,nM,36332883.0,"Synthesis, evaluation and mechanism exploration of 2-(N-(3-nitrophenyl)-N-phenylsulfonyl)aminoacetohydroxamic acids as novel urease inhibitors.",YPSPPVDYSAOVGT-UHFFFAOYSA-N
168286714.0,Cc1ccccc1S(=O)(=O)N(CC(=O)NO)c1cccc([N+](=O)[O-])c1,PubChem,Helicobacter pylori,urease inhibition,IC50,7100,nM,36332883.0,"Synthesis, evaluation and mechanism exploration of 2-(N-(3-nitrophenyl)-N-phenylsulfonyl)aminoacetohydroxamic acids as novel urease inhibitors.",YQUJDVSAVGZGJJ-UHFFFAOYSA-N
CHEMBL462481,NCC(=O)NCC(=O)NO,ChEMBL,Helicobacter pylori,B,IC50,790,nM,CHEMBL1140057,Inhibition of Helicobacter pylori urease,NXTDAODSZSXXAY-UHFFFAOYSA-N
CHEMBL4128654,Cc1cccc(C)c1NC(=O)CCSc1nnc(Cc2csc(NC(=O)c3ccccc3)n2)o1,ChEMBL,Helicobacter pylori,B,IC50,2790,nM,CHEMBL4118270,Inhibition of Campylobacter pylori urease preincubated for 5 mins followed by urea addition measured after 10 mins by Berthelot assay,CVZPHWAGJBROOY-UHFFFAOYSA-N
CHEMBL4126448,Cc1cccc(NC(=O)CCSc2nnc(Cc3csc(NC(=O)c4ccccc4)n3)o2)c1,ChEMBL,Helicobacter pylori,B,IC50,12230,nM,CHEMBL4118270,Inhibition of Campylobacter pylori urease preincubated for 5 mins followed by urea addition measured after 10 mins by Berthelot assay,DNILGHNBLUMIFF-UHFFFAOYSA-N
CHEMBL4129736,Cc1ccccc1NC(=O)CCSc1nnc(Cc2csc(NC(=O)c3ccccc3)n2)o1,ChEMBL,Helicobacter pylori,B,IC50,7470,nM,CHEMBL4118270,Inhibition of Campylobacter pylori urease preincubated for 5 mins followed by urea addition measured after 10 mins by Berthelot assay,GECZYMUBMFBGAQ-UHFFFAOYSA-N
CHEMBL4126727,CCc1ccc(NC(=O)CCSc2nnc(Cc3csc(NC(=O)c4ccccc4)n3)o2)cc1,ChEMBL,Helicobacter pylori,B,IC50,43180,nM,CHEMBL4118270,Inhibition of Campylobacter pylori urease preincubated for 5 mins followed by urea addition measured after 10 mins by Berthelot assay,HVFVSATWQIUZPE-UHFFFAOYSA-N
CHEMBL4127682,Cc1cccc(NC(=O)CCSc2nnc(Cc3csc(NC(=O)c4ccccc4)n3)o2)c1C,ChEMBL,Helicobacter pylori,B,IC50,48160,nM,CHEMBL4118270,Inhibition of Campylobacter pylori urease preincubated for 5 mins followed by urea addition measured after 10 mins by Berthelot assay,ILJHQWSBACOHHA-UHFFFAOYSA-N
CHEMBL4130000,O=C(CCSc1nnc(Cc2csc(NC(=O)c3ccccc3)n2)o1)Nc1ccccc1,ChEMBL,Helicobacter pylori,B,IC50,2950,nM,CHEMBL4118270,Inhibition of Campylobacter pylori urease preincubated for 5 mins followed by urea addition measured after 10 mins by Berthelot assay,IZLQFPOKCNWPDV-UHFFFAOYSA-N
CHEMBL4126307,Cc1ccc(NC(=O)CCSc2nnc(Cc3csc(NC(=O)c4ccccc4)n3)o2)cc1,ChEMBL,Helicobacter pylori,B,IC50,29180,nM,CHEMBL4118270,Inhibition of Campylobacter pylori urease preincubated for 5 mins followed by urea addition measured after 10 mins by Berthelot assay,JYBGVILDMQPKEE-UHFFFAOYSA-N
CHEMBL4127102,CCOc1ccc(NC(=O)CCSc2nnc(Cc3csc(NC(=O)c4ccccc4)n3)o2)cc1,ChEMBL,Helicobacter pylori,B,IC50,23240,nM,CHEMBL4118270,Inhibition of Campylobacter pylori urease preincubated for 5 mins followed by urea addition measured after 10 mins by Berthelot assay,KEXYXTJVCOEYQW-UHFFFAOYSA-N
CHEMBL4127272,Cc1ccc(C)c(NC(=O)CCSc2nnc(Cc3csc(NC(=O)c4ccccc4)n3)o2)c1,ChEMBL,Helicobacter pylori,B,IC50,15250,nM,CHEMBL4118270,Inhibition of Campylobacter pylori urease preincubated for 5 mins followed by urea addition measured after 10 mins by Berthelot assay,MMRLHQQRXPRXJD-UHFFFAOYSA-N
CHEMBL4129997,CCc1ccccc1NC(=O)CCSc1nnc(Cc2csc(NC(=O)c3ccccc3)n2)o1,ChEMBL,Helicobacter pylori,B,IC50,2580,nM,CHEMBL4118270,Inhibition of Campylobacter pylori urease preincubated for 5 mins followed by urea addition measured after 10 mins by Berthelot assay,NCKQCCBCQFXYNJ-UHFFFAOYSA-N
CHEMBL4128510,Cc1ccc(NC(=O)CCSc2nnc(Cc3csc(NC(=O)c4ccccc4)n3)o2)cc1C,ChEMBL,Helicobacter pylori,B,IC50,34190,nM,CHEMBL4118270,Inhibition of Campylobacter pylori urease preincubated for 5 mins followed by urea addition measured after 10 mins by Berthelot assay,PTXNKGBLWWCMPO-UHFFFAOYSA-N
CHEMBL4129880,Cc1cc(C)cc(NC(=O)CCSc2nnc(Cc3csc(NC(=O)c4ccccc4)n3)o2)c1,ChEMBL,Helicobacter pylori,B,IC50,52120,nM,CHEMBL4118270,Inhibition of Campylobacter pylori urease preincubated for 5 mins followed by urea addition measured after 10 mins by Berthelot assay,QOXHJAKDKFFIBY-UHFFFAOYSA-N
CHEMBL4286810,CC(C)=CCN1C(=O)/C(=N/NC(=O)c2ccc(F)cc2)c2ccccc21,ChEMBL,Helicobacter pylori,B,IC50,154000,nM,CHEMBL4265894,Inhibition of Helicobacter pylori urease after 50 mins by indophenol method,AOHYJLWKSLIUOI-RELWKKBWSA-N
CHEMBL4294712,CC(C)=CCN1C(=O)/C(=N/NC(=O)c2ccc(Cl)cc2)c2ccccc21,ChEMBL,Helicobacter pylori,B,IC50,143000,nM,CHEMBL4265894,Inhibition of Helicobacter pylori urease after 50 mins by indophenol method,DUBUMHULHFIOPF-RELWKKBWSA-N
CHEMBL4289842,CC(C)=CCN1C(=O)/C(=N/NC(=O)c2cccc(Br)c2)c2ccccc21,ChEMBL,Helicobacter pylori,B,IC50,27600,nM,CHEMBL4265894,Inhibition of Helicobacter pylori urease after 50 mins by indophenol method,IECQOKUWUOQIJF-RELWKKBWSA-N
CHEMBL4278846,CC(C)=CCN1C(=O)/C(=N/NC(=O)c2cc(C)cc(C)c2)c2ccccc21,ChEMBL,Helicobacter pylori,B,IC50,4380,nM,CHEMBL4265894,Inhibition of Helicobacter pylori urease after 50 mins by indophenol method,INHXVCXCANVLAR-BSYVCWPDSA-N
CHEMBL4291305,CC(C)=CCN1C(=O)/C(=N/NC(=O)c2ccccc2)c2ccccc21,ChEMBL,Helicobacter pylori,B,IC50,129000,nM,CHEMBL4265894,Inhibition of Helicobacter pylori urease after 50 mins by indophenol method,JFPFUICGRQUHME-DYTRJAOYSA-N
CHEMBL4279579,CC(C)=CCN1C(=O)/C(=N/NC(=O)c2ccc(C(C)C)cc2)c2ccccc21,ChEMBL,Helicobacter pylori,B,IC50,14900,nM,CHEMBL4265894,Inhibition of Helicobacter pylori urease after 50 mins by indophenol method,MTYUFSJLTHENBI-DARPEHSRSA-N
CHEMBL4294307,CC(C)=CCN1C(=O)/C(=N/NC(=O)c2ccc(Oc3ccccc3)cc2)c2ccccc21,ChEMBL,Helicobacter pylori,B,IC50,22700,nM,CHEMBL4265894,Inhibition of Helicobacter pylori urease after 50 mins by indophenol method,NUYXFMYQIYNDCV-SOYKGTTHSA-N
CHEMBL4290913,CC(C)=CCN1C(=O)/C(=N/NC(=O)c2ccc(C(C)(C)C)cc2)c2ccccc21,ChEMBL,Helicobacter pylori,B,IC50,19500,nM,CHEMBL4265894,Inhibition of Helicobacter pylori urease after 50 mins by indophenol method,PPKDCZCQYYRBDP-NJNXFGOHSA-N
CHEMBL4293217,CC(C)=CCN1C(=O)/C(=N/NC(=O)c2cccc(C(F)(F)F)c2)c2ccccc21,ChEMBL,Helicobacter pylori,B,IC50,65800,nM,CHEMBL4265894,Inhibition of Helicobacter pylori urease after 50 mins by indophenol method,PSLLZTXYWXRKSG-XIEYBQDHSA-N
CHEMBL4277785,COc1ccc(C(=O)N/N=C2/C(=O)N(CC=C(C)C)c3ccccc32)cc1F,ChEMBL,Helicobacter pylori,B,IC50,3820,nM,CHEMBL4265894,Inhibition of Helicobacter pylori urease after 50 mins by indophenol method,PSVBZPIAHGWZPI-FCDQGJHFSA-N
CHEMBL4281503,CC(C)=CCN1C(=O)/C(=N/NC(=O)c2ccc(Br)cc2)c2ccccc21,ChEMBL,Helicobacter pylori,B,IC50,83900,nM,CHEMBL4265894,Inhibition of Helicobacter pylori urease after 50 mins by indophenol method,RAFZPWKKPCHMMM-RELWKKBWSA-N
CHEMBL4285715,CC(C)=CCN1C(=O)/C(=N/Nc2ccccc2)c2ccccc21,ChEMBL,Helicobacter pylori,B,IC50,300000,nM,CHEMBL4265894,Inhibition of Helicobacter pylori urease after 50 mins by indophenol method,SMWQOVNKWQCQDX-DYTRJAOYSA-N
CHEMBL4279161,CC(C)=CCN1C(=O)/C(=N/NC(=O)c2cccc(Cl)c2)c2ccccc21,ChEMBL,Helicobacter pylori,B,IC50,38100,nM,CHEMBL4265894,Inhibition of Helicobacter pylori urease after 50 mins by indophenol method,UMGOYPLMENRFQF-RELWKKBWSA-N
CHEMBL4283043,CC(C)=CCN1C(=O)/C(=N/NC(=O)c2ccc(C(F)(F)F)cc2)c2ccccc21,ChEMBL,Helicobacter pylori,B,IC50,44100,nM,CHEMBL4265894,Inhibition of Helicobacter pylori urease after 50 mins by indophenol method,UNUTYUDNMHHHDU-XIEYBQDHSA-N
CHEMBL4289384,CC(C)=CCN1C(=O)/C(=N/NC(=O)c2ccc(C)cc2)c2ccccc21,ChEMBL,Helicobacter pylori,B,IC50,29900,nM,CHEMBL4265894,Inhibition of Helicobacter pylori urease after 50 mins by indophenol method,YYJYHOFZAJSUNQ-ZBJSNUHESA-N
136118944.0,Oc1ccc(-c2nc3ccc(Br)cc3[nH]2)cc1,PubChem,Helicobacter pylori ,urease inhibition,IC50,8300,nM,31112894.0,Synthetic heterocyclic candidates as promising α-glucosidase inhibitors: An overview.,SVFKAMFTYKXDLW-UHFFFAOYSA-N
163408943.0,O=C(N/N=C/c1c(O)ccc2c(=O)cc(-c3ccc(F)cc3)oc12)c1ccccc1,PubChem,Helicobacter pylori ,urease inhibition,IC50,1207,nM,35305460.0,An overview on the synthetic urease inhibitors with structure-activity relationship and molecular docking.,CDTZFFAOENGXSO-DHRITJCHSA-N
155512762.0,O=[N+]([O-])c1ccc(S(=O)(=O)N/N=C(\c2ccccc2)c2ccc(O)cc2)cc1,PubChem,Helicobacter pylori ,urease inhibition,IC50,3900,nM,35305460.0,An overview on the synthetic urease inhibitors with structure-activity relationship and molecular docking.,IABGABHQOYYTAP-FMQUCBEESA-N
17522609.0,COc1ccc(-c2nc(C(=O)NC3CCCCC3)cs2)cc1,PubChem,Helicobacter pylori ,urease inhibition,IC50,1820,nM,35305460.0,An overview on the synthetic urease inhibitors with structure-activity relationship and molecular docking.,LVTLEBUFTDITNA-UHFFFAOYSA-N
17133586.0,COc1ccc(C(=O)NNC(=O)c2cc(Cl)cc(Cl)c2)cc1,PubChem,Helicobacter pylori ,urease inhibition,IC50,870,nM,35305460.0,An overview on the synthetic urease inhibitors with structure-activity relationship and molecular docking.,LZOQJBQVXOVQNR-UHFFFAOYSA-N
9594754.0,Cc1ccc(/C=N/Nc2nc(-c3ccc(Br)cc3)cs2)cc1,PubChem,Helicobacter pylori ,urease inhibition,IC50,110,nM,35305460.0,An overview on the synthetic urease inhibitors with structure-activity relationship and molecular docking.,NWRVBUQIDLTUHI-VXLYETTFSA-N
5355594.0,COc1ccc(/C=C/C(=O)c2ccc(O)cc2)cc1,PubChem,Helicobacter pylori ,urease inhibition,IC50,11510,nM,35305460.0,An overview on the synthetic urease inhibitors with structure-activity relationship and molecular docking.,RTCVAWRRHHSOCC-NYYWCZLTSA-N
168286052.0,O=[N+]([O-])c1ccc(S(=O)(=O)Nc2nnc(-c3ccc(C(c4c[nH]c5ccc(Br)cc45)c4c[nH]c5ccc(Br)cc45)cc3)s2)c([N+](=O)[O-])c1,PubChem,Helicobacter pylori ,urease inhibition,IC50,500,nM,35305460.0,An overview on the synthetic urease inhibitors with structure-activity relationship and molecular docking.,UZGASXAASHFBGH-UHFFFAOYSA-N
386828,CNC(=O)c1cn(C2CC2)c2cc(N3CCN(C(C)=O)CC3)c(F)cc2c1=O,BindingDB,Helicobacter pylori ,urease inhibition,IC50,1290,nM,https://doi.org/10.1016/j.ejmech.2022.114273,,AMZGYPDVTAOARB-UHFFFAOYSA-N
386836,NNC(=O)c1cn(C2CC2)c2cc(N3CCN(CC(=O)Nc4ccc(C(=O)/C=C/c5ccccc5)cc4)CC3)c(F)cc2c1=O,BindingDB,Helicobacter pylori ,urease inhibition,IC50,812060,nM,https://doi.org/10.1016/j.ejmech.2022.114274,,GGJQDIHTWAEPTQ-AWNIVKPZSA-N
386839,CNC(=O)c1cn2c3c(c(N4CCN(C)CC4)c(F)cc3c1=O)OC[C@@H]2C,BindingDB,Helicobacter pylori ,urease inhibition,IC50,2890,nM,https://doi.org/10.1016/j.ejmech.2022.114275,,HAROZUBOLLPGLB-NSHDSACASA-N
386829,CNC(=O)c1cn(C2CC2)c2cc(N3CCN(C(=O)c4ccccc4)CC3)c(F)cc2c1=O,BindingDB,Helicobacter pylori ,urease inhibition,IC50,2495800,nM,https://doi.org/10.1016/j.ejmech.2022.114276,,IZKMYJWJZLTCFZ-UHFFFAOYSA-N
386837,COc1cc(/C=C/C(=O)c2ccc(NC(=O)CN3CCN(c4cc5c(cc4F)c(=O)c(C(=O)NN)cn5C4CC4)CC3)cc2)cc(OC)c1OC,BindingDB,Helicobacter pylori ,urease inhibition,IC50,912010,nM,https://doi.org/10.1016/j.ejmech.2022.114277,,KOMIFYDHCIMPGO-NYYWCZLTSA-N
386826,O=C(CN1CCN(c2cc3c(cc2F)c(=O)c(C(=O)NO)cn3C2CC2)CC1)Nc1ccc(C(=O)/C=C/c2ccccc2)cc1,BindingDB,Helicobacter pylori ,urease inhibition,IC50,19300,nM,https://doi.org/10.1016/j.ejmech.2022.114278,,MJNSQSIGMLRVGT-AWNIVKPZSA-N
386838,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)NO)cn1c23,BindingDB,Helicobacter pylori ,urease inhibition,IC50,2200,nM,https://doi.org/10.1016/j.ejmech.2022.114279,,NSYSXUJOMHQGEP-JTQLQIEISA-N
386830,CNC(=O)c1cn(C2CC2)c2cc(N3CCN(C(=O)c4cc(OC)c(OC)c(OC)c4)CC3)c(F)cc2c1=O,BindingDB,Helicobacter pylori ,urease inhibition,IC50,2920,nM,https://doi.org/10.1016/j.ejmech.2022.114280,,NTAASJMKCQQJSZ-UHFFFAOYSA-N
386833,CC(=O)N1CCN(c2cc3c(cc2F)c(=O)c(C(=O)NN)cn3C2CC2)CC1,BindingDB,Helicobacter pylori ,urease inhibition,IC50,1220,nM,https://doi.org/10.1016/j.ejmech.2022.114281,,OFIYSEZTSKZNTP-UHFFFAOYSA-N
386834,NNC(=O)c1cn(C2CC2)c2cc(N3CCN(C(=O)c4ccccc4)CC3)c(F)cc2c1=O,BindingDB,Helicobacter pylori ,urease inhibition,IC50,250440,nM,https://doi.org/10.1016/j.ejmech.2022.114282,,OQCZYBSOICBZNT-UHFFFAOYSA-N
386824,O=C(NO)c1cn(C2CC2)c2cc(N3CCN(C(=O)c4ccccc4)CC3)c(F)cc2c1=O,BindingDB,Helicobacter pylori ,urease inhibition,IC50,18930,nM,https://doi.org/10.1016/j.ejmech.2022.114283,,OVWYSTKMSPNBLW-UHFFFAOYSA-N
386822,CC(=O)NO,BindingDB,Helicobacter pylori ,urease inhibition,IC50,120000,nM,https://doi.org/10.1016/j.ejmech.2022.114284,,RRUDCFGSUDOHDG-UHFFFAOYSA-N
386832,CNC(=O)c1cn(C2CC2)c2cc(N3CCN(CC(=O)Nc4ccc(C(=O)/C=C/c5cc(OC)c(OC)c(OC)c5)cc4)CC3)c(F)cc2c1=O,BindingDB,Helicobacter pylori ,urease inhibition,IC50,630900,nM,https://doi.org/10.1016/j.ejmech.2022.114285,,SSMRAELGNKPPKT-LFYBBSHMSA-N
386823,CC(=O)N1CCN(c2cc3c(cc2F)c(=O)c(C(=O)NO)cn3C2CC2)CC1,BindingDB,Helicobacter pylori ,urease inhibition,IC50,2220,nM,https://doi.org/10.1016/j.ejmech.2022.114286,,SUMIHSMKWQVZDC-UHFFFAOYSA-N
386831,CNC(=O)c1cn(C2CC2)c2cc(N3CCN(CC(=O)Nc4ccc(C(=O)/C=C/c5ccccc5)cc4)CC3)c(F)cc2c1=O,BindingDB,Helicobacter pylori ,urease inhibition,IC50,2413400,nM,https://doi.org/10.1016/j.ejmech.2022.114287,,TYOUWTRGYLZOGF-VGOFMYFVSA-N
386840,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)NN)cn1c23,BindingDB,Helicobacter pylori ,urease inhibition,IC50,772340,nM,https://doi.org/10.1016/j.ejmech.2022.114288,,UNWAQKQQFZTCBT-JTQLQIEISA-N
386821,CC(=O)N1CCN(c2cc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1,BindingDB,Helicobacter pylori ,urease inhibition,IC50,2260,nM,https://doi.org/10.1016/j.ejmech.2022.114289,,VIISGXFPKLOPRI-UHFFFAOYSA-N
386835,COc1cc(C(=O)N2CCN(c3cc4c(cc3F)c(=O)c(C(=O)NN)cn4C3CC3)CC2)cc(OC)c1OC,BindingDB,Helicobacter pylori ,urease inhibition,IC50,2080,nM,https://doi.org/10.1016/j.ejmech.2022.114290,,VRDWWLJLPSPRRR-UHFFFAOYSA-N
386825,COc1cc(C(=O)N2CCN(c3cc4c(cc3F)c(=O)c(C(=O)NO)cn4C3CC3)CC2)cc(OC)c1OC,BindingDB,Helicobacter pylori ,urease inhibition,IC50,7170,nM,https://doi.org/10.1016/j.ejmech.2022.114291,,WMPWYMFIZZXAMW-UHFFFAOYSA-N
386827,COc1cc(/C=C/C(=O)c2ccc(NC(=O)CN3CCN(c4cc5c(cc4F)c(=O)c(C(=O)NO)cn5C4CC4)CC3)cc2)cc(OC)c1OC,BindingDB,Helicobacter pylori ,urease inhibition,IC50,949250,nM,https://doi.org/10.1016/j.ejmech.2022.114292,,XMQRYRMVSKNQCK-NYYWCZLTSA-N
54685433.0,O=C1OCC(O)=C1c1ccc(Br)cc1,PubChem,Helicobacter pylori ,urease inhibition,IC50,16800,nM,26048027.0,"Synthesis, molecular docking and biological evaluation of 3-arylfuran-2(5H)-ones as anti-gastric ulcer agent.",BSGAYQXKDCICFN-UHFFFAOYSA-N
85689664.0,O=C1OCC(O)=C1c1ccc(Cl)cc1Cl,PubChem,Helicobacter pylori ,urease inhibition,IC50,100000,nM,26048027.0,"Synthesis, molecular docking and biological evaluation of 3-arylfuran-2(5H)-ones as anti-gastric ulcer agent.",HNRUAWCIOYSKOP-UHFFFAOYSA-N
54706943.0,COc1ccc(C2=C(O)COC2=O)cc1OC,PubChem,Helicobacter pylori ,urease inhibition,IC50,20400,nM,26048027.0,"Synthesis, molecular docking and biological evaluation of 3-arylfuran-2(5H)-ones as anti-gastric ulcer agent.",OLTOJSITAUVGKL-UHFFFAOYSA-N
67482681.0,O=C1OCC(O)=C1c1ccc(F)cc1,PubChem,Helicobacter pylori ,urease inhibition,IC50,27700,nM,26048027.0,"Synthesis, molecular docking and biological evaluation of 3-arylfuran-2(5H)-ones as anti-gastric ulcer agent.",RUJFNTRAXWKQIS-UHFFFAOYSA-N
85518325.0,O=C1OCC(O)=C1c1ccc(Cl)cc1,PubChem,Helicobacter pylori ,urease inhibition,IC50,18500,nM,26048027.0,"Synthesis, molecular docking and biological evaluation of 3-arylfuran-2(5H)-ones as anti-gastric ulcer agent.",UYPDVVUCYUYANE-UHFFFAOYSA-N
85518320.0,O=C1OCC(O)=C1c1ccccc1Cl,PubChem,Helicobacter pylori ,urease inhibition,IC50,100000,nM,26048027.0,"Synthesis, molecular docking and biological evaluation of 3-arylfuran-2(5H)-ones as anti-gastric ulcer agent.",VJMDFARPIKAFRO-UHFFFAOYSA-N
122185041.0,CCOc1ccc(C2=C(O)COC2=O)cc1OCC,PubChem,Helicobacter pylori ,urease inhibition,IC50,23400,nM,26048027.0,"Synthesis, molecular docking and biological evaluation of 3-arylfuran-2(5H)-ones as anti-gastric ulcer agent.",XUQUCPMUBIRXIP-UHFFFAOYSA-N
122185032.0,O=C1OCC(O)=C1c1cccc(OCc2ccccc2)c1,PubChem,Helicobacter pylori ,urease inhibition,IC50,31500,nM,26048027.0,"Synthesis, molecular docking and biological evaluation of 3-arylfuran-2(5H)-ones as anti-gastric ulcer agent.",YYZWXGWNWOWAGK-UHFFFAOYSA-N
85518344.0,O=C1OCC(O)=C1c1ccc(Cl)c(Cl)c1,PubChem,Helicobacter pylori ,urease inhibition,IC50,28700,nM,26048027.0,"Synthesis, molecular docking and biological evaluation of 3-arylfuran-2(5H)-ones as anti-gastric ulcer agent.",ZMKCVJDQEMPYNS-UHFFFAOYSA-N
22353732.0,O=[N+]([O-])c1ccc(CNc2ccc([N+](=O)[O-])cc2)cc1,PubChem,Helicobacter pylori ATCC 43504,urease inhibition,IC50,76250,nM,26113187.0,"Synthesis and evaluation of N-analogs of 1,2-diarylethane as Helicobacter pylori urease inhibitors.",ANCXYUTYAMHILA-UHFFFAOYSA-N
43717960.0,O=[N+]([O-])c1cccc(NCc2ccc(O)c(O)c2)c1,PubChem,Helicobacter pylori ATCC 43504,urease inhibition,IC50,5925,nM,26113187.0,"Synthesis and evaluation of N-analogs of 1,2-diarylethane as Helicobacter pylori urease inhibitors.",BBGNUVHIGIXVMU-UHFFFAOYSA-N
13462598.0,COc1ccc(NCc2cccc([N+](=O)[O-])c2)cc1,PubChem,Helicobacter pylori ATCC 43504,urease inhibition,IC50,319200,nM,26113187.0,"Synthesis and evaluation of N-analogs of 1,2-diarylethane as Helicobacter pylori urease inhibitors.",DQMQBJQBYREIBB-UHFFFAOYSA-N
292416.0,CN(C)c1ccc(CNc2ccc(Cl)cc2)cc1,PubChem,Helicobacter pylori ATCC 43504,urease inhibition,IC50,500000,nM,26113187.0,"Synthesis and evaluation of N-analogs of 1,2-diarylethane as Helicobacter pylori urease inhibitors.",FWKSHKCNVMHOIW-UHFFFAOYSA-N
43226460.0,O=[N+]([O-])c1ccc(NCc2ccc(O)cc2)cc1,PubChem,Helicobacter pylori ATCC 43504,urease inhibition,IC50,18180,nM,26113187.0,"Synthesis and evaluation of N-analogs of 1,2-diarylethane as Helicobacter pylori urease inhibitors.",GGNYHWLRWFSDMB-UHFFFAOYSA-N
12953968.0,COc1ccc(CNc2cccc([N+](=O)[O-])c2)cc1OC,PubChem,Helicobacter pylori ATCC 43504,urease inhibition,IC50,50400,nM,26113187.0,"Synthesis and evaluation of N-analogs of 1,2-diarylethane as Helicobacter pylori urease inhibitors.",GKZPMQCLHPWAPT-UHFFFAOYSA-N
961574.0,COc1ccc(NCc2ccc(Cl)cc2)cc1,PubChem,Helicobacter pylori ATCC 43504,urease inhibition,IC50,500000,nM,26113187.0,"Synthesis and evaluation of N-analogs of 1,2-diarylethane as Helicobacter pylori urease inhibitors.",GQRCXKTWRYIKBP-UHFFFAOYSA-N
3130391.0,O=[N+]([O-])c1cccc(CNc2cccc([N+](=O)[O-])c2)c1,PubChem,Helicobacter pylori ATCC 43504,urease inhibition,IC50,85000,nM,26113187.0,"Synthesis and evaluation of N-analogs of 1,2-diarylethane as Helicobacter pylori urease inhibitors.",HPZWCINBEYAGKS-UHFFFAOYSA-N
1133060.0,O=[N+]([O-])c1ccc(CNc2cccc(Cl)c2)cc1,PubChem,Helicobacter pylori ATCC 43504,urease inhibition,IC50,236500,nM,26113187.0,"Synthesis and evaluation of N-analogs of 1,2-diarylethane as Helicobacter pylori urease inhibitors.",IGRXUUQJHWHBCP-UHFFFAOYSA-N
22353735.0,O=[N+]([O-])c1ccc(NCc2ccc(Cl)cc2)cc1,PubChem,Helicobacter pylori ATCC 43504,urease inhibition,IC50,51650,nM,26113187.0,"Synthesis and evaluation of N-analogs of 1,2-diarylethane as Helicobacter pylori urease inhibitors.",JUDCNWPXYMSGHM-UHFFFAOYSA-N
13462606.0,O=[N+]([O-])c1cccc(NCc2ccc(Cl)cc2)c1,PubChem,Helicobacter pylori ATCC 43504,urease inhibition,IC50,57500,nM,26113187.0,"Synthesis and evaluation of N-analogs of 1,2-diarylethane as Helicobacter pylori urease inhibitors.",LQOYLPSTYSVVDG-UHFFFAOYSA-N
43718150.0,O=[N+]([O-])c1ccccc1NCc1ccc(O)c(O)c1,PubChem,Helicobacter pylori ATCC 43504,urease inhibition,IC50,45100,nM,26113187.0,"Synthesis and evaluation of N-analogs of 1,2-diarylethane as Helicobacter pylori urease inhibitors.",MBVZXZZGEOYGIX-UHFFFAOYSA-N
43719772.0,O=[N+]([O-])c1ccc(NCc2ccc(O)c(O)c2)cc1,PubChem,Helicobacter pylori ATCC 43504,urease inhibition,IC50,1270,nM,26113187.0,"Synthesis and evaluation of N-analogs of 1,2-diarylethane as Helicobacter pylori urease inhibitors.",PVBVTVYQWIAKKJ-UHFFFAOYSA-N
964801.0,Clc1ccc(NCc2ccc3c(c2)OCO3)cc1,PubChem,Helicobacter pylori ATCC 43504,urease inhibition,IC50,500000,nM,26113187.0,"Synthesis and evaluation of N-analogs of 1,2-diarylethane as Helicobacter pylori urease inhibitors.",QNSGPBQRNKLKKS-UHFFFAOYSA-N
855075.0,COc1ccc(NCc2ccc(N(C)C)cc2)cc1,PubChem,Helicobacter pylori ATCC 43504,urease inhibition,IC50,500000,nM,26113187.0,"Synthesis and evaluation of N-analogs of 1,2-diarylethane as Helicobacter pylori urease inhibitors.",RDKKBVHEHXPZQH-UHFFFAOYSA-N
1133085.0,O=[N+]([O-])c1cccc(CNc2cccc(Cl)c2)c1,PubChem,Helicobacter pylori ATCC 43504,urease inhibition,IC50,410300,nM,26113187.0,"Synthesis and evaluation of N-analogs of 1,2-diarylethane as Helicobacter pylori urease inhibitors.",SGLUBPKKPRQWNY-UHFFFAOYSA-N
4367631.0,COc1ccc(CNc2ccc(Cl)cc2)cc1OC,PubChem,Helicobacter pylori ATCC 43504,urease inhibition,IC50,500000,nM,26113187.0,"Synthesis and evaluation of N-analogs of 1,2-diarylethane as Helicobacter pylori urease inhibitors.",UUDIOVAKFLQNMI-UHFFFAOYSA-N
12095765.0,O=[N+]([O-])c1ccccc1CNc1ccc(Cl)cc1,PubChem,Helicobacter pylori ATCC 43504,urease inhibition,IC50,238700,nM,26113187.0,"Synthesis and evaluation of N-analogs of 1,2-diarylethane as Helicobacter pylori urease inhibitors.",UZVULDPLKQSWIM-UHFFFAOYSA-N
292417.0,CN(C)c1ccc(CNc2cccc([N+](=O)[O-])c2)cc1,PubChem,Helicobacter pylori ATCC 43504,urease inhibition,IC50,44600,nM,26113187.0,"Synthesis and evaluation of N-analogs of 1,2-diarylethane as Helicobacter pylori urease inhibitors.",XRIMRWXYXFTWBM-UHFFFAOYSA-N
9274128.0,O=[N+]([O-])c1ccc(CNc2cccc([N+](=O)[O-])c2)cc1,PubChem,Helicobacter pylori ATCC 43504,urease inhibition,IC50,64900,nM,26113187.0,"Synthesis and evaluation of N-analogs of 1,2-diarylethane as Helicobacter pylori urease inhibitors.",YWUGCEXQDMDSAH-UHFFFAOYSA-N
682326.0,O=[N+]([O-])c1cccc(NCc2ccc3c(c2)OCO3)c1,PubChem,Helicobacter pylori ATCC 43504,urease inhibition,IC50,36700,nM,26113187.0,"Synthesis and evaluation of N-analogs of 1,2-diarylethane as Helicobacter pylori urease inhibitors.",ZWBFXQHQQBRJCG-UHFFFAOYSA-N
5029.0,COCCCOc1ccnc(CS(=O)c2nc3ccccc3[nH]2)c1C,PubChem,Helicobacter pylori ATCC 43504,urease inhibition,IC50,290,nM,27524377.0,"1,2-Benzisoselenazol-3(2H)-one Derivatives As a New Class of Bacterial Urease Inhibitors.",YREYEVIYCVEVJK-UHFFFAOYSA-N
145982554.0,O=C(CCOc1ccc(Br)cc1)NO,PubChem,Helicobacter pylori NCTC 11637 = CCUG 17874 = ATCC 43504,urease inhibition,IC50,860,nM,29983280.0,The synthesis and evaluation of phenoxyacylhydroxamic acids as potential agents for Helicobacter pylori infections.,ABGOXDQHZLJEIF-UHFFFAOYSA-N
145982844.0,Cc1ccccc1OCCC(=O)NO,PubChem,Helicobacter pylori NCTC 11637 = CCUG 17874 = ATCC 43504,urease inhibition,IC50,6740,nM,29983280.0,The synthesis and evaluation of phenoxyacylhydroxamic acids as potential agents for Helicobacter pylori infections.,APYATXZUPCMFIY-UHFFFAOYSA-N
145982793.0,O=C(CCOc1ccc(Cl)c(Cl)c1)NO,PubChem,Helicobacter pylori NCTC 11637 = CCUG 17874 = ATCC 43504,urease inhibition,IC50,"475,5",nM,29983280.0,The synthesis and evaluation of phenoxyacylhydroxamic acids as potential agents for Helicobacter pylori infections.,BPBPGQGZBCXYEW-UHFFFAOYSA-N
145983251.0,Cc1ccc(OCCC(=O)NO)cc1,PubChem,Helicobacter pylori NCTC 11637 = CCUG 17874 = ATCC 43504,urease inhibition,IC50,1380,nM,29983280.0,The synthesis and evaluation of phenoxyacylhydroxamic acids as potential agents for Helicobacter pylori infections.,DMMZARSUKYKNMP-UHFFFAOYSA-N
145983865.0,O=C(COc1ccccc1[N+](=O)[O-])NO,PubChem,Helicobacter pylori NCTC 11637 = CCUG 17874 = ATCC 43504,urease inhibition,IC50,144300,nM,29983280.0,The synthesis and evaluation of phenoxyacylhydroxamic acids as potential agents for Helicobacter pylori infections.,DMPMRZBIHXPRNA-UHFFFAOYSA-N
145983154.0,O=C(CCOc1ccc(F)cc1)NO,PubChem,Helicobacter pylori NCTC 11637 = CCUG 17874 = ATCC 43504,urease inhibition,IC50,1130,nM,29983280.0,The synthesis and evaluation of phenoxyacylhydroxamic acids as potential agents for Helicobacter pylori infections.,DZVCZHPJDNVZCN-UHFFFAOYSA-N
145983362.0,O=C(CCOc1cccc(Cl)c1)NO,PubChem,Helicobacter pylori NCTC 11637 = CCUG 17874 = ATCC 43504,urease inhibition,IC50,1230,nM,29983280.0,The synthesis and evaluation of phenoxyacylhydroxamic acids as potential agents for Helicobacter pylori infections.,FCWUJCZULURONB-UHFFFAOYSA-N
145984684.0,Cc1cc(C)cc(OCCC(=O)NO)c1,PubChem,Helicobacter pylori NCTC 11637 = CCUG 17874 = ATCC 43504,urease inhibition,IC50,10400,nM,29983280.0,The synthesis and evaluation of phenoxyacylhydroxamic acids as potential agents for Helicobacter pylori infections.,FDYYOMJPLCRLKL-UHFFFAOYSA-N
145984854.0,O=C(COc1cc(F)cc(F)c1)NO,PubChem,Helicobacter pylori NCTC 11637 = CCUG 17874 = ATCC 43504,urease inhibition,IC50,205400,nM,29983280.0,The synthesis and evaluation of phenoxyacylhydroxamic acids as potential agents for Helicobacter pylori infections.,FQQLGLURNDNEMF-UHFFFAOYSA-N
49859552.0,COc1ccc(OCCC(=O)NO)cc1,PubChem,Helicobacter pylori NCTC 11637 = CCUG 17874 = ATCC 43504,urease inhibition,IC50,8350,nM,29983280.0,The synthesis and evaluation of phenoxyacylhydroxamic acids as potential agents for Helicobacter pylori infections.,FUYUBQGLJLXLIJ-UHFFFAOYSA-N
145985446.0,O=C(CCOc1cc(Cl)ccc1Cl)NO,PubChem,Helicobacter pylori NCTC 11637 = CCUG 17874 = ATCC 43504,urease inhibition,IC50,13100,nM,29983280.0,The synthesis and evaluation of phenoxyacylhydroxamic acids as potential agents for Helicobacter pylori infections.,GBLVGAJTZKFOJS-UHFFFAOYSA-N
24705008.0,Cc1cccc(OCCC(=O)NO)c1,PubChem,Helicobacter pylori NCTC 11637 = CCUG 17874 = ATCC 43504,urease inhibition,IC50,3380,nM,29983280.0,The synthesis and evaluation of phenoxyacylhydroxamic acids as potential agents for Helicobacter pylori infections.,GMIBUONZOFCIDT-UHFFFAOYSA-N
145986005.0,O=C(COc1cc(Cl)cc(Cl)c1)NO,PubChem,Helicobacter pylori NCTC 11637 = CCUG 17874 = ATCC 43504,urease inhibition,IC50,3220,nM,29983280.0,The synthesis and evaluation of phenoxyacylhydroxamic acids as potential agents for Helicobacter pylori infections.,HXAUILAKUMPZTC-UHFFFAOYSA-N
145982530.0,Cc1cc(C)cc(OCC(=O)NO)c1,PubChem,Helicobacter pylori NCTC 11637 = CCUG 17874 = ATCC 43504,urease inhibition,IC50,41900,nM,29983280.0,The synthesis and evaluation of phenoxyacylhydroxamic acids as potential agents for Helicobacter pylori infections.,KMHQUDRVQGBYJY-UHFFFAOYSA-N
130677882.0,Cc1ccccc1OCC(=O)NO,PubChem,Helicobacter pylori NCTC 11637 = CCUG 17874 = ATCC 43504,urease inhibition,IC50,153600,nM,29983280.0,The synthesis and evaluation of phenoxyacylhydroxamic acids as potential agents for Helicobacter pylori infections.,MBUSGHOSZOHWHT-UHFFFAOYSA-N
130723063.0,O=C(COc1ccccc1F)NO,PubChem,Helicobacter pylori NCTC 11637 = CCUG 17874 = ATCC 43504,urease inhibition,IC50,121500,nM,29983280.0,The synthesis and evaluation of phenoxyacylhydroxamic acids as potential agents for Helicobacter pylori infections.,NCJCGDJEBJCCAB-UHFFFAOYSA-N
3252458.0,O=C(COc1ccccc1)NO,PubChem,Helicobacter pylori NCTC 11637 = CCUG 17874 = ATCC 43504,urease inhibition,IC50,131200,nM,29983280.0,The synthesis and evaluation of phenoxyacylhydroxamic acids as potential agents for Helicobacter pylori infections.,NUWNUNRECZGDII-UHFFFAOYSA-N
95562486.0,O=C(COc1ccccc1Cl)NO,PubChem,Helicobacter pylori NCTC 11637 = CCUG 17874 = ATCC 43504,urease inhibition,IC50,78500,nM,29983280.0,The synthesis and evaluation of phenoxyacylhydroxamic acids as potential agents for Helicobacter pylori infections.,OJFQYWJSQVDTIE-UHFFFAOYSA-N
145984703.0,O=C(COc1cc(Cl)ccc1Cl)NO,PubChem,Helicobacter pylori NCTC 11637 = CCUG 17874 = ATCC 43504,urease inhibition,IC50,9020,nM,29983280.0,The synthesis and evaluation of phenoxyacylhydroxamic acids as potential agents for Helicobacter pylori infections.,PCHFVIQSTZMWLL-UHFFFAOYSA-N
11183280.0,O=C(COc1ccc(Cl)cc1)NO,PubChem,Helicobacter pylori NCTC 11637 = CCUG 17874 = ATCC 43504,urease inhibition,IC50,1260,nM,29983280.0,The synthesis and evaluation of phenoxyacylhydroxamic acids as potential agents for Helicobacter pylori infections.,PDBUPNZIGMKVIC-UHFFFAOYSA-N
145984003.0,O=C(COc1c(Cl)cccc1Cl)NO,PubChem,Helicobacter pylori NCTC 11637 = CCUG 17874 = ATCC 43504,urease inhibition,IC50,353200,nM,29983280.0,The synthesis and evaluation of phenoxyacylhydroxamic acids as potential agents for Helicobacter pylori infections.,PQXZBKRPUYJYEK-UHFFFAOYSA-N
145984790.0,O=C(COc1ccc(Cl)c(Cl)c1)NO,PubChem,Helicobacter pylori NCTC 11637 = CCUG 17874 = ATCC 43504,urease inhibition,IC50,520,nM,29983280.0,The synthesis and evaluation of phenoxyacylhydroxamic acids as potential agents for Helicobacter pylori infections.,PRWRUMDOXRYISJ-UHFFFAOYSA-N
21935074.0,O=C(CCOc1ccccc1)NO,PubChem,Helicobacter pylori NCTC 11637 = CCUG 17874 = ATCC 43504,urease inhibition,IC50,4180,nM,29983280.0,The synthesis and evaluation of phenoxyacylhydroxamic acids as potential agents for Helicobacter pylori infections.,PTLMVTWTWJSJBJ-UHFFFAOYSA-N
145983648.0,O=C(CCOc1ccc(Cl)cc1)NO,PubChem,Helicobacter pylori NCTC 11637 = CCUG 17874 = ATCC 43504,urease inhibition,IC50/Ki,247,nM,29983280.0,The synthesis and evaluation of phenoxyacylhydroxamic acids as potential agents for Helicobacter pylori infections.,QMLVCGMEQRGAEC-UHFFFAOYSA-N
60651050.0,O=C(COc1cccc(Cl)c1)NO,PubChem,Helicobacter pylori NCTC 11637 = CCUG 17874 = ATCC 43504,urease inhibition,IC50,10400,nM,29983280.0,The synthesis and evaluation of phenoxyacylhydroxamic acids as potential agents for Helicobacter pylori infections.,QUEVHMMLANOLNU-UHFFFAOYSA-N
59336415.0,Cc1ccc(OCC(=O)NO)cc1,PubChem,Helicobacter pylori NCTC 11637 = CCUG 17874 = ATCC 43504,urease inhibition,IC50,57100,nM,29983280.0,The synthesis and evaluation of phenoxyacylhydroxamic acids as potential agents for Helicobacter pylori infections.,ROCWONVWEMBXNL-UHFFFAOYSA-N
145984816.0,O=C(CCOc1cccc(F)c1)NO,PubChem,Helicobacter pylori NCTC 11637 = CCUG 17874 = ATCC 43504,urease inhibition,IC50,2050,nM,29983280.0,The synthesis and evaluation of phenoxyacylhydroxamic acids as potential agents for Helicobacter pylori infections.,SMOQNTFTIJEFNP-UHFFFAOYSA-N
24990996.0,O=C(COc1ccc(F)cc1)NO,PubChem,Helicobacter pylori NCTC 11637 = CCUG 17874 = ATCC 43504,urease inhibition,IC50,18900,nM,29983280.0,The synthesis and evaluation of phenoxyacylhydroxamic acids as potential agents for Helicobacter pylori infections.,SPFNNZGLHWHHLL-UHFFFAOYSA-N
130841018.0,O=C(COc1cccc(F)c1)NO,PubChem,Helicobacter pylori NCTC 11637 = CCUG 17874 = ATCC 43504,urease inhibition,IC50,27000,nM,29983280.0,The synthesis and evaluation of phenoxyacylhydroxamic acids as potential agents for Helicobacter pylori infections.,VKPCAEXNFRWRDN-UHFFFAOYSA-N
145985598.0,O=C(CCOc1cc(F)cc(F)c1)NO,PubChem,Helicobacter pylori NCTC 11637 = CCUG 17874 = ATCC 43504,urease inhibition,IC50,5090,nM,29983280.0,The synthesis and evaluation of phenoxyacylhydroxamic acids as potential agents for Helicobacter pylori infections.,VUMXNIQSCQYYAR-UHFFFAOYSA-N
145984444.0,O=C(COc1cccc([N+](=O)[O-])c1)NO,PubChem,Helicobacter pylori NCTC 11637 = CCUG 17874 = ATCC 43504,urease inhibition,IC50,94700,nM,29983280.0,The synthesis and evaluation of phenoxyacylhydroxamic acids as potential agents for Helicobacter pylori infections.,WAFLXIBCHPZCSL-UHFFFAOYSA-N
15125023.0,COc1ccc(OCC(=O)NO)cc1,PubChem,Helicobacter pylori NCTC 11637 = CCUG 17874 = ATCC 43504,urease inhibition,IC50,49500,nM,29983280.0,The synthesis and evaluation of phenoxyacylhydroxamic acids as potential agents for Helicobacter pylori infections.,WWKAAMICBMJUPI-UHFFFAOYSA-N
95562485.0,O=C(COc1ccc([N+](=O)[O-])cc1)NO,PubChem,Helicobacter pylori NCTC 11637 = CCUG 17874 = ATCC 43504,urease inhibition,IC50,62100,nM,29983280.0,The synthesis and evaluation of phenoxyacylhydroxamic acids as potential agents for Helicobacter pylori infections.,XPEANGDBINWTML-UHFFFAOYSA-N
130842494.0,Cc1cccc(OCC(=O)NO)c1,PubChem,Helicobacter pylori NCTC 11637 = CCUG 17874 = ATCC 43504,urease inhibition,IC50,85100,nM,29983280.0,The synthesis and evaluation of phenoxyacylhydroxamic acids as potential agents for Helicobacter pylori infections.,XUDPLPBCTJZYJS-UHFFFAOYSA-N
239786.0,O=C(COc1ccc(Cl)cc1Cl)NO,PubChem,Helicobacter pylori NCTC 11637 = CCUG 17874 = ATCC 43504,urease inhibition,IC50,830,nM,29983280.0,The synthesis and evaluation of phenoxyacylhydroxamic acids as potential agents for Helicobacter pylori infections.,YUBQYFJKIYWZBD-UHFFFAOYSA-N
145982738.0,O=C(COc1cccc(Cl)c1Cl)NO,PubChem,Helicobacter pylori NCTC 11637 = CCUG 17874 = ATCC 43504,urease inhibition,IC50,178700,nM,29983280.0,The synthesis and evaluation of phenoxyacylhydroxamic acids as potential agents for Helicobacter pylori infections.,YZXQNGMHEZAMJA-UHFFFAOYSA-N
3598816.0,O=C(COc1ccc(Br)cc1)NO,PubChem,Helicobacter pylori NCTC 11637 = CCUG 17874 = ATCC 43504,urease inhibition,IC50,5350,nM,29983280.0,The synthesis and evaluation of phenoxyacylhydroxamic acids as potential agents for Helicobacter pylori infections.,ZFQNABYNZGTXCR-UHFFFAOYSA-N
145953677.0,O=C(CCNc1ccc([N+](=O)[O-])cc1)NO,PubChem,Helicobacter pylori NCTC 11637 = CCUG 17874 = ATCC 43504,urease inhibition,IC50,1230,nM,30006158.0,Arylamino containing hydroxamic acids as potent urease inhibitors for the treatment of Helicobacter pylori infection.,AFXIJERQZPPMDO-UHFFFAOYSA-N
145972714.0,O=C(CCNc1cccc(Cl)c1Cl)NO,PubChem,Helicobacter pylori NCTC 11637 = CCUG 17874 = ATCC 43504,urease inhibition,IC50,3830,nM,30006158.0,Arylamino containing hydroxamic acids as potent urease inhibitors for the treatment of Helicobacter pylori infection.,BPAQVZKIEHNHMG-UHFFFAOYSA-N
145950756.0,O=C(CNc1c(Cl)cccc1Cl)NO,PubChem,Helicobacter pylori NCTC 11637 = CCUG 17874 = ATCC 43504,urease inhibition,IC50,191000,nM,30006158.0,Arylamino containing hydroxamic acids as potent urease inhibitors for the treatment of Helicobacter pylori infection.,CNFJCZPHFMBDGQ-UHFFFAOYSA-N
145960261.0,COc1cc(NCC(=O)NO)cc(OC)c1,PubChem,Helicobacter pylori NCTC 11637 = CCUG 17874 = ATCC 43504,urease inhibition,IC50,2280,nM,30006158.0,Arylamino containing hydroxamic acids as potent urease inhibitors for the treatment of Helicobacter pylori infection.,DYLCPDSLUSRNCF-UHFFFAOYSA-N
145952401.0,O=C(CNc1ccccc1Br)NO,PubChem,Helicobacter pylori NCTC 11637 = CCUG 17874 = ATCC 43504,urease inhibition,IC50,12300,nM,30006158.0,Arylamino containing hydroxamic acids as potent urease inhibitors for the treatment of Helicobacter pylori infection.,FMUFTGZWFCYSPY-UHFFFAOYSA-N
145953083.0,O=C(CNc1ccc(Br)cc1)NO,PubChem,Helicobacter pylori NCTC 11637 = CCUG 17874 = ATCC 43504,urease inhibition,IC50,2010,nM,30006158.0,Arylamino containing hydroxamic acids as potent urease inhibitors for the treatment of Helicobacter pylori infection.,FPDCDPFEDUCBBV-UHFFFAOYSA-N
145974309.0,Cc1cc(C)cc(NCC(=O)NO)c1,PubChem,Helicobacter pylori NCTC 11637 = CCUG 17874 = ATCC 43504,urease inhibition,IC50,2120,nM,30006158.0,Arylamino containing hydroxamic acids as potent urease inhibitors for the treatment of Helicobacter pylori infection.,GMIGVZLRNAFOTE-UHFFFAOYSA-N
145974348.0,O=C(CNc1cc(Cl)cc(Cl)c1)NO,PubChem,Helicobacter pylori NCTC 11637 = CCUG 17874 = ATCC 43504,urease inhibition,IC50,8515,nM,30006158.0,Arylamino containing hydroxamic acids as potent urease inhibitors for the treatment of Helicobacter pylori infection.,GSEALNRYJFBDSA-UHFFFAOYSA-N
145951218.0,COc1ccccc1NCCC(=O)NO,PubChem,Helicobacter pylori NCTC 11637 = CCUG 17874 = ATCC 43504,urease inhibition,IC50,1640,nM,30006158.0,Arylamino containing hydroxamic acids as potent urease inhibitors for the treatment of Helicobacter pylori infection.,HGTSTIDXMIZUEW-UHFFFAOYSA-N
145973840.0,O=C(CCNc1cccc([N+](=O)[O-])c1)NO,PubChem,Helicobacter pylori NCTC 11637 = CCUG 17874 = ATCC 43504,urease inhibition,IC50,5100,nM,30006158.0,Arylamino containing hydroxamic acids as potent urease inhibitors for the treatment of Helicobacter pylori infection.,IHUYPPIEMCGLGJ-UHFFFAOYSA-N
130005353.0,O=C(CNc1cccc(Cl)c1)NO,PubChem,Helicobacter pylori NCTC 11637 = CCUG 17874 = ATCC 43504,urease inhibition,IC50,1150,nM,30006158.0,Arylamino containing hydroxamic acids as potent urease inhibitors for the treatment of Helicobacter pylori infection.,IMEMHNRBVPDUMM-UHFFFAOYSA-N
145958473.0,O=C(CCNc1ccccc1[N+](=O)[O-])NO,PubChem,Helicobacter pylori NCTC 11637 = CCUG 17874 = ATCC 43504,urease inhibition,IC50,10530,nM,30006158.0,Arylamino containing hydroxamic acids as potent urease inhibitors for the treatment of Helicobacter pylori infection.,IULDZUNLFLGBHL-UHFFFAOYSA-N
145957965.0,O=C(CNc1cc(Cl)ccc1Cl)NO,PubChem,Helicobacter pylori NCTC 11637 = CCUG 17874 = ATCC 43504,urease inhibition,IC50,1640,nM,30006158.0,Arylamino containing hydroxamic acids as potent urease inhibitors for the treatment of Helicobacter pylori infection.,IXELTIFPAMBDTO-UHFFFAOYSA-N
145959103.0,O=C(CCNc1ccccc1)NO,PubChem,Helicobacter pylori NCTC 11637 = CCUG 17874 = ATCC 43504,urease inhibition,IC50,1220,nM,30006158.0,Arylamino containing hydroxamic acids as potent urease inhibitors for the treatment of Helicobacter pylori infection.,JBWKUNVHMFZGMP-UHFFFAOYSA-N
145956167.0,O=C(CCNc1cc(Cl)cc(Cl)c1)NO,PubChem,Helicobacter pylori NCTC 11637 = CCUG 17874 = ATCC 43504,urease inhibition,IC50,"1971,5",nM,30006158.0,Arylamino containing hydroxamic acids as potent urease inhibitors for the treatment of Helicobacter pylori infection.,KRPIERJODNQEGY-UHFFFAOYSA-N
145949441.0,O=C(CNc1cccc(Cl)c1Cl)NO,PubChem,Helicobacter pylori NCTC 11637 = CCUG 17874 = ATCC 43504,urease inhibition,IC50,14800,nM,30006158.0,Arylamino containing hydroxamic acids as potent urease inhibitors for the treatment of Helicobacter pylori infection.,LNAKBECIBOQFRQ-UHFFFAOYSA-N
145958315.0,O=C(CNc1cc(F)cc(F)c1)NO,PubChem,Helicobacter pylori NCTC 11637 = CCUG 17874 = ATCC 43504,urease inhibition,IC50,5110,nM,30006158.0,Arylamino containing hydroxamic acids as potent urease inhibitors for the treatment of Helicobacter pylori infection.,MALZRMQGYYVSLD-UHFFFAOYSA-N
145958008.0,O=C(CCNc1ccccc1Cl)NO,PubChem,Helicobacter pylori NCTC 11637 = CCUG 17874 = ATCC 43504,urease inhibition,IC50,"2982,5",nM,30006158.0,Arylamino containing hydroxamic acids as potent urease inhibitors for the treatment of Helicobacter pylori infection.,MEPIQQPWCFEGTP-UHFFFAOYSA-N
145951194.0,O=C(CCNc1ccc(Cl)cc1Cl)NO,PubChem,Helicobacter pylori NCTC 11637 = CCUG 17874 = ATCC 43504,urease inhibition,IC50,79,nM,30006158.0,Arylamino containing hydroxamic acids as potent urease inhibitors for the treatment of Helicobacter pylori infection.,MMPFUJBCLCJWAT-UHFFFAOYSA-N
145955567.0,O=C(CCNc1cc(Cl)ccc1Cl)NO,PubChem,Helicobacter pylori NCTC 11637 = CCUG 17874 = ATCC 43504,urease inhibition,IC50,14975,nM,30006158.0,Arylamino containing hydroxamic acids as potent urease inhibitors for the treatment of Helicobacter pylori infection.,MZSIXICMZYRDTL-UHFFFAOYSA-N
130006294.0,O=C(CNc1ccccc1Cl)NO,PubChem,Helicobacter pylori NCTC 11637 = CCUG 17874 = ATCC 43504,urease inhibition,IC50,58900,nM,30006158.0,Arylamino containing hydroxamic acids as potent urease inhibitors for the treatment of Helicobacter pylori infection.,ONBIBHYDOKLEQK-UHFFFAOYSA-N
203276.0,O=C(CNc1ccc(Cl)c(Cl)c1)NO,PubChem,Helicobacter pylori NCTC 11637 = CCUG 17874 = ATCC 43504,urease inhibition,IC50,21180,nM,30006158.0,Arylamino containing hydroxamic acids as potent urease inhibitors for the treatment of Helicobacter pylori infection.,RMRRVOJUHINZFO-UHFFFAOYSA-N
145971740.0,O=C(CCNc1ccc(Cl)c(Cl)c1)NO,PubChem,Helicobacter pylori NCTC 11637 = CCUG 17874 = ATCC 43504,urease inhibition,IC50,19805,nM,30006158.0,Arylamino containing hydroxamic acids as potent urease inhibitors for the treatment of Helicobacter pylori infection.,RTHWSIGJWWQEPS-UHFFFAOYSA-N
129928412.0,O=C(CNc1ccc(F)cc1)NO,PubChem,Helicobacter pylori NCTC 11637 = CCUG 17874 = ATCC 43504,urease inhibition,IC50,7410,nM,30006158.0,Arylamino containing hydroxamic acids as potent urease inhibitors for the treatment of Helicobacter pylori infection.,SGOGEIFJDQKSOL-UHFFFAOYSA-N
145954976.0,O=C(CNc1ccc(Cl)cc1Cl)NO,PubChem,Helicobacter pylori NCTC 11637 = CCUG 17874 = ATCC 43504,urease inhibition,IC50,66100,nM,30006158.0,Arylamino containing hydroxamic acids as potent urease inhibitors for the treatment of Helicobacter pylori infection.,SJVFJYMJUARESM-UHFFFAOYSA-N
145959452.0,Cc1cc(C)cc(NCCC(=O)NO)c1,PubChem,Helicobacter pylori NCTC 11637 = CCUG 17874 = ATCC 43504,urease inhibition,IC50,2930,nM,30006158.0,Arylamino containing hydroxamic acids as potent urease inhibitors for the treatment of Helicobacter pylori infection.,UJXLXCGMCIQPKM-UHFFFAOYSA-N
46769547.0,Cc1ccc(NCC(=O)NO)cc1,PubChem,Helicobacter pylori NCTC 11637 = CCUG 17874 = ATCC 43504,urease inhibition,IC50,3910,nM,30006158.0,Arylamino containing hydroxamic acids as potent urease inhibitors for the treatment of Helicobacter pylori infection.,USAJLDRNEOVHJV-UHFFFAOYSA-N
145956231.0,O=C(CNc1cccc([N+](=O)[O-])c1)NO,PubChem,Helicobacter pylori NCTC 11637 = CCUG 17874 = ATCC 43504,urease inhibition,IC50,8210,nM,30006158.0,Arylamino containing hydroxamic acids as potent urease inhibitors for the treatment of Helicobacter pylori infection.,UZNMGXUGAOXQOY-UHFFFAOYSA-N
46769546.0,O=C(CNc1ccc(Cl)cc1)NO,PubChem,Helicobacter pylori NCTC 11637 = CCUG 17874 = ATCC 43504,urease inhibition,IC50,2470,nM,30006158.0,Arylamino containing hydroxamic acids as potent urease inhibitors for the treatment of Helicobacter pylori infection.,VCFKLAMFXOWTOW-UHFFFAOYSA-N
145959786.0,O=C(CN1CCCc2ccccc21)NO,PubChem,Helicobacter pylori NCTC 11637 = CCUG 17874 = ATCC 43504,urease inhibition,IC50,71100,nM,30006158.0,Arylamino containing hydroxamic acids as potent urease inhibitors for the treatment of Helicobacter pylori infection.,VGYIBZGOCPCKSV-UHFFFAOYSA-N
145956007.0,O=C(CCNc1cc(F)cc(F)c1)NO,PubChem,Helicobacter pylori NCTC 11637 = CCUG 17874 = ATCC 43504,urease inhibition,IC50,1520,nM,30006158.0,Arylamino containing hydroxamic acids as potent urease inhibitors for the treatment of Helicobacter pylori infection.,VOEBGVUOHGPBOR-UHFFFAOYSA-N
145950151.0,O=C(CNc1cccc(Br)c1)NO,PubChem,Helicobacter pylori NCTC 11637 = CCUG 17874 = ATCC 43504,urease inhibition,IC50,24480,nM,30006158.0,Arylamino containing hydroxamic acids as potent urease inhibitors for the treatment of Helicobacter pylori infection.,VQNVFDYHZBGABB-UHFFFAOYSA-N
145955823.0,O=C(CCNc1ccc(F)cc1)NO,PubChem,Helicobacter pylori NCTC 11637 = CCUG 17874 = ATCC 43504,urease inhibition,IC50,9040,nM,30006158.0,Arylamino containing hydroxamic acids as potent urease inhibitors for the treatment of Helicobacter pylori infection.,VYWUWPNYWVIXLF-UHFFFAOYSA-N
22716931.0,O=C(CNc1ccccc1)NO,PubChem,Helicobacter pylori NCTC 11637 = CCUG 17874 = ATCC 43504,urease inhibition,IC50,4670,nM,30006158.0,Arylamino containing hydroxamic acids as potent urease inhibitors for the treatment of Helicobacter pylori infection.,XAKNTJATDGXKFC-UHFFFAOYSA-N
129927960.0,COc1ccc(NCC(=O)NO)cc1,PubChem,Helicobacter pylori NCTC 11637 = CCUG 17874 = ATCC 43504,urease inhibition,IC50,69800,nM,30006158.0,Arylamino containing hydroxamic acids as potent urease inhibitors for the treatment of Helicobacter pylori infection.,XFSQTPHEUDEBAO-UHFFFAOYSA-N
145955675.0,O=C(CCNc1c(Cl)cccc1Cl)NO,PubChem,Helicobacter pylori NCTC 11637 = CCUG 17874 = ATCC 43504,urease inhibition,IC50,25000,nM,30006158.0,Arylamino containing hydroxamic acids as potent urease inhibitors for the treatment of Helicobacter pylori infection.,XJOBHUGXKQWDGD-UHFFFAOYSA-N
145956736.0,COc1cccc(NCC(=O)NO)c1,PubChem,Helicobacter pylori NCTC 11637 = CCUG 17874 = ATCC 43504,urease inhibition,IC50,21810,nM,30006158.0,Arylamino containing hydroxamic acids as potent urease inhibitors for the treatment of Helicobacter pylori infection.,YEKDGZZWZZFEAY-UHFFFAOYSA-N
145953035.0,O=C(CCN1CCCc2ccccc21)NO,PubChem,Helicobacter pylori NCTC 11637 = CCUG 17874 = ATCC 43504,urease inhibition,IC50,21130,nM,30006158.0,Arylamino containing hydroxamic acids as potent urease inhibitors for the treatment of Helicobacter pylori infection.,YMIYNELKKBOMBU-UHFFFAOYSA-N
145959872.0,O=C(CCNc1ccccc1Br)NO,PubChem,Helicobacter pylori NCTC 11637 = CCUG 17874 = ATCC 43504,urease inhibition,IC50,7315,nM,30006158.0,Arylamino containing hydroxamic acids as potent urease inhibitors for the treatment of Helicobacter pylori infection.,ZSGMVEHEDJDICE-UHFFFAOYSA-N
145958045.0,COc1ccccc1NCC(=O)NO,PubChem,Helicobacter pylori NCTC 11637 = CCUG 17874 = ATCC 43504,urease inhibition,IC50,152000,nM,30006158.0,Arylamino containing hydroxamic acids as potent urease inhibitors for the treatment of Helicobacter pylori infection.,ZZSHGYWRVNJOSV-UHFFFAOYSA-N
5280343.0,O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12,PubChem,Helicobacter pylori/Homo sapiens,urease inhibition,IC50,7170,nM,23567958.0/35694689.0,"Insights into the recent progress in the medicinal chemistry of pyranopyrimidine analogs./Synthesis, structure-activity relationship analysis and kinetics study of reductive derivatives of flavonoids as Helicobacter pylori urease inhibitors.",REFJWTPEDVJJIY-UHFFFAOYSA-N
132601482.0,O=C(CC(O)c1cc(Cl)ccc1OCc1ccccc1)NO,PubChem,Helicobacter pylori/Homo sapiens,urease inhibition,IC50,150,nM,27492194.0/35305460.0,"3-Arylpropionylhydroxamic acid derivatives as Helicobacter pylori urease inhibitors: Synthesis, molecular docking and biological evaluation./An overview on the synthetic urease inhibitors with structure-activity relationship and molecular docking.",BGNASDWWZLEMPF-UHFFFAOYSA-N
145991509.0,CC(C)=CCn1c(O)c(N=Nc2ccccc2)c2ccccc21,PubChem,Helicobacter pylori/Homo sapiens,urease inhibition,IC50/MIC,200000,nM,30170940.0/35305460.0,"An overview on the synthetic urease inhibitors with structure-activity relationship and molecular docking./Developing potential Helicobacter pylori urease inhibitors from novel oxoindoline derivatives: Synthesis, biological evaluation and in silico study.",PVYQYORKGKRENI-UHFFFAOYSA-N
3657.0,NC(=O)NO,PubChem,Helicobacter pylori/Homo sapiens,urease inhibition,IC50,88750,nM,35305460.0/38516598.0,An overview on the synthetic urease inhibitors with structure-activity relationship and molecular docking./In vitro biological evaluation and in silico studies of linear diarylheptanoids from Curcuma aromatica Salisb. as urease inhibitors.,VSNHCAURESNICA-UHFFFAOYSA-N
172455978.0,O=C(O)C(CP(=O)(O)CC(C(=O)O)c1ccc(O)c(O)c1)c1ccc(O)c(O)c1,PubChem,Helicobacter pylori/Sporosarcina pasteurii,urease inhibition,IC50/Ki,9950,nM,37290184.0,Inhibitory activity of catecholic phosphonic and phosphinic acids against Helicobacter pylori ureolysis.,ALOLTPJPBRYBDN-UHFFFAOYSA-N
172440200.0,O=C(O)C(CP(=O)(O)O)c1cc(O)c(O)cc1Br,PubChem,Helicobacter pylori/Sporosarcina pasteurii,urease inhibition,IC50/Ki,42550,nM,37290184.0,Inhibitory activity of catecholic phosphonic and phosphinic acids against Helicobacter pylori ureolysis.,PQJQOCDZFUBLFM-UHFFFAOYSA-N
172446415.0,O=C(O)CCP(=O)(O)CC(C(=O)O)c1ccc(O)c(O)c1,PubChem,Helicobacter pylori/Sporosarcina pasteurii,urease inhibition,IC50/Ki,7705,nM,37290184.0,Inhibitory activity of catecholic phosphonic and phosphinic acids against Helicobacter pylori ureolysis.,RAMJXWIOBUJIKL-UHFFFAOYSA-N
172470549.0,COC(=O)C(CP(=O)(O)O)c1ccc(O)c(O)c1,PubChem,Helicobacter pylori/Sporosarcina pasteurii,urease inhibition,IC50/Ki,54700,nM,37290184.0,Inhibitory activity of catecholic phosphonic and phosphinic acids against Helicobacter pylori ureolysis.,XFZQVTZGWAKHFZ-UHFFFAOYSA-N
172441090.0,O=C(O)C(C[P+](=O)O)c1ccc(O)c(O)c1,PubChem,Helicobacter pylori/Sporosarcina pasteurii,urease inhibition,IC50/Ki,34650,nM,37290184.0,Inhibitory activity of catecholic phosphonic and phosphinic acids against Helicobacter pylori ureolysis.,YBIOHAWXJPMEAY-UHFFFAOYSA-O
172461642.0,COC(=O)CCP(=O)(O)CC(C(=O)OC)c1ccc(O)c(O)c1,PubChem,Helicobacter pylori/Sporosarcina pasteurii,urease inhibition,IC50/Ki,320000,nM,37290184.0,Inhibitory activity of catecholic phosphonic and phosphinic acids against Helicobacter pylori ureolysis.,YMLSILNEPXPGAT-UHFFFAOYSA-N
172461878.0,COC(=O)C(CP(=O)(O)CC(C(=O)OC)c1ccc(O)c(O)c1)c1ccc(O)c(O)c1,PubChem,Helicobacter pylori/Sporosarcina pasteurii,urease inhibition,IC50/Ki,56775,nM,37290184.0,Inhibitory activity of catecholic phosphonic and phosphinic acids against Helicobacter pylori ureolysis.,KRURFQLWMTZXRZ-UHFFFAOYSA-N
